Myocardial infarction, with ST-elevation

I9_STEMI

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — I21.1, I21.2, I21.3 Cause of death: ICD-10 — I21.1, I21.2, I21.3 2 out of 7 registries used, show all original rules.	9102
4. Check minimum number of events None	9102
5. Include endpoints None	9102
6. Filter based on genotype QC (FinnGen only)	7994

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze: DF2

NAME	I9_STEMI
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	I21[1-3]
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	I21[1-3]
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Myocardial infarction, with ST-elevation based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	7994	2024	5970
Unadjusted period prevalence (%)	2.23	0.72	2.74
Median age at first event (years)	67.50	70.50	66.48

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
8269: Matched controls
82683

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

FN2EC

NOMESCO Finland

Transcatheter coronary thrombectomy

44.5

315.7

187

Angiography of the heart and coronary arteries

3.8

307.7

1427

4346

AN4

Balloon angioplasty and drug eluding stent

7.5

307.7

1060

1600

C10AA05

ATC

atorvastatin; oral

2.8

307.7

5053

29984

B01AC04

ATC

clopidogrel; oral

5.5

307.7

3986

11944

I25

ICD-10 Finland

Chronic ischaemic heart disease

4.7

307.7

1215

2918

C09AA05

ATC

ramipril; oral

3.3

307.7

4023

18335

I21.20

ICD-10 Finland

Acute transmural myocardial infarction with other localization no detected stenosis of coronary artery

+∞

307.7

315

AN1

Coronary angiography

5.4

307.7

2887

7439

I21.2

ICD-10 Finland

Acute transmural myocardial infarction of other sites

6914.5

307.7

649

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

5.2

307.7

5137

19806

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

3.0

307.7

2807

12045

FN1BT

NOMESCO Finland

Extensive endovascular dilatation of coronary (PTCA) arteries

8.3

307.7

793

1041

I25.1

ICD-10 Finland

Atherosclerotic heart disease

8.9

307.7

6075

19611

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

3.8

307.7

2418

8118

I21.1

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

1133.0

307.7

629

C10AX09

ATC

ezetimibe; oral

3.5

307.7

2551

9407

I25.2

ICD-10 Finland

Old myocardial infarction

11.8

307.7

3379

4575

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

7.3

307.7

1307

2066

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

4.4

307.7

1879

5186

ZXD00

NOMESCO Finland

Emergency procedure

7.7

307.7

796

1134

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

8.4

307.7

5569

16308

Single vessel balloon catheter extension

6.0

307.7

671

1192

AN2

Balloon angioplasty, including several vessels

6.3

307.7

757

1293

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

9.0

307.7

2318

3428

C07AB07

ATC

bisoprolol; oral

3.1

307.7

5944

37197

I21.11

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

4503599627370496.0

307.7

2542

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

9.2

307.7

2146

3030

AN3

Balloon angioplasty and metallic stent

10.1

307.7

1150

1298

I21.39

ICD-10 Finland

Acute transmural myocardial infarction with unspecified localization unspecified coronary artery status

776.9

307.7

838

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

3.1

307.7

3700

17001

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

3.5

307.7

2942

11265

I20.09

ICD-10 Finland

Unstable angina

3.8

307.7

1203

3554

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

3.7

307.7

1302

4015

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

13.1

307.7

6190

15344

I21.01

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

8.1

307.7

575

755

B01AC24

ATC

ticagrelor; oral

17.5

307.7

2008

1485

I21.29

ICD-10 Finland

Acute transmural myocardial infarction with other localization unspecified coronary artery status

4065.2

307.7

762

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

4.2

307.7

1056

2764

C01DA14

ATC

isosorbide mononitrate; oral

3.4

307.7

3382

13864

I21.21

ICD-10 Finland

Acute transmural myocardial infarction with another location stenosed coronary artery

7539.8

307.7

702

FN1AT

NOMESCO Finland

Endovascular dilatation of coronary arteries (PTCA)

9.2

307.7

1916

2619

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

3.7

307.7

1386

4265

I21.99

ICD-10 Finland

Myocardial infarction (acute) UNS unspecified coronary artery status

4.9

307.7

755

1647

I21.19

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

+∞

307.7

2374

ZXD05

NOMESCO Finland

Urgent procedure

2.7

307.7

3470

17276

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

3.5

307.7

1696

5739

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

4.1

307.7

1012

2745

I21.10

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

15843.5

307.7

1342

I21.90

ICD-10 Finland

Myocardial infarction (acute) UNS no detected stenosis of the coronary artery

6.1

298.0

538

932

XF400

NOMESCO Finland

ECG with 12 standard connections

2.6

283.5

2158

9915

FNG10

NOMESCO Finland

Embolectomy of coronary artery

37.7

275.5

170

280

Kela drug reimbursment

Clopidogrel

6.6

271.9

448

707

C10AA01

ATC

simvastatin; oral

2.2

268.2

4937

32891

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

3.6

265.5

947

2831

I21.3

ICD-10 Finland

Acute transmural myocardial infarction of unspecified site

626.6

247.5

244

ANB

Coronary thrombectomy

32.2

244.8

158

I20.01

ICD-10 Finland

Unstable angina

4.2

240.8

676

1703

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

3.4

238.3

969

3143

FN2AB

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA), drug-eluting balloon

5.9

238.2

442

784

I21.00

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

6.4

234.4

402

660

I21.12

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

+∞

228.2

218

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.2

228.1

2744

15181

I21.30

ICD-10 Finland

Acute transmural myocardial infarction with unspecified location no detected stenosis of coronary artery

2156.8

228.0

220

K76

ICPC

Ischaemic heart dis without angina

4.5

216.3

558

1315

C07AB02

ATC

metoprolol; systemic

2.2

213.6

2617

14511

I20.00

ICD-10 Finland

Unstable angina

3.8

197.8

638

1771

I21.09

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

5.2

190.7

406

815

B01AC22

ATC

prasugrel; oral

15.2

186.3

164

110

I20.99

ICD-10 Finland

Angina pectoris, unspecified

2.7

181.0

1095

4408

FN2AA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA), balloon only

7.8

173.5

242

317

R07.4

ICD-10 Finland

Chest pain, unspecified

2.0

170.1

2812

17120

I21.40

ICD-10 Finland

Acute subendocardial infarction no detected stenosis of the coronary artery

3.8

163.9

524

1442

I25.5

ICD-10 Finland

Ischaemic cardiomyopathy

4.4

162.7

428

1021

C03CA01

ATC

furosemide; systemic

1.9

160.4

3912

26904

I46.0

ICD-10 Finland

Cardiac arrest with successful resuscitation

5.1

155.0

337

688

I50.1

ICD-10 Finland

Left ventricular failure

2.7

148.8

890

3545

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.2

144.4

1429

7137

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

2.3

139.5

1269

6116

I50.9

ICD-10 Finland

Heart failure, unspecified

1.9

136.9

2157

12749

Coronary artery bypass surgery

3.5

132.1

476

1416

WX872

NOMESCO Finland

Intensive care

2.8

128.8

706

2681

FN2CA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA), treating more than one main trunk during a single procedure

5.0

128.5

280

572

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

3.4

117.7

441

1344

XF402

NOMESCO Finland

ECG with work load test

2.2

113.4

1152

5771

B01AC06

ATC

acetylsalicylic acid; oral

2.7

111.2

636

2464

I21

ICD-10 Finland

Acute myocardial infarction

11.4

102.7

107

FNC20

NOMESCO Finland

Aorto-coronary venous bypass with two distal anastomoses

3.3

98.2

389

1226

I50.0

ICD-10 Finland

Congestive heart failure

2.0

98.0

1177

6255

103

Kela drug reimbursment

Diabetes, insulin-treated

1.7

97.8

2808

19436

FN1BE

NOMESCO Finland

Ultrasound examination of coronary arteries through catheter

5.9

95.4

173

299

I21.31

ICD-10 Finland

Acute transmural myocardial infarction with unspecified localization stenosed coronary artery

+∞

95.0

I22.8

ICD-10 Finland

Subsequent myocardial infarction of other sites

19.1

94.5

C03DA01

ATC

spironolactone; oral

1.9

92.7

1413

8132

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.3

91.3

777

3608

Catheterization and pressure measurement of the left side of the heart

3.6

90.4

304

862

I20.90

ICD-10 Finland

Angina pectoris, unspecified

2.6

86.8

538

2163

I25.8

ICD-10 Finland

Other forms of chronic ischaemic heart disease

3.8

82.4

262

715

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.6

82.1

2563

17941

FNC30

NOMESCO Finland

Aorto-coronary venous bypass with three distal anastomoses

3.4

82.0

305

923

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

2.5

80.6

516

2106

K84

ICPC

Heart disease other

2.9

80.6

405

1462

294

Kela drug reimbursment

Alirocumab and evolocumab for the treatment of hypercholesterolaemia and dyslipidaemia

7.5

79.9

115

156

FL1AC

NOMESCO Finland

Left cardioangiography

3.6

78.4

270

778

A10AC01

ATC

insulin (human); parenteral

2.1

78.3

834

4222

I21.91

ICD-10 Finland

Myocardial infarction (acute) UNS stenosed coronary artery

7.2

76.4

114

161

Z50.0

ICD-10 Finland

Cardiac rehabilitation

4.3

75.7

198

469

I23.0

ICD-10 Finland

Haemopericardium as current complication following acute myocardial infarction

12.4

75.2

I21.18

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

+∞

75.1

FN1CB

NOMESCO Finland

Coronary flow reserve measurement with pressure wire

3.0

75.0

349

1207

3015

Kela drug reimbursment

Alirocumab and evolocumab for the treatment of hypercholesterolaemia and dyslipidaemia

6.6

73.7

119

183

A10BA02

ATC

metformin; oral

1.6

73.0

2761

20090

Multi-vessel balloon catheter extension

5.5

72.9

141

259

201

Kela drug reimbursment

Chronic cardiac insufficiency

2.0

72.6

830

4306

287

Kela drug reimbursment

Ticagrelor 60 mg

40.2

72.2

I22.19

ICD-10 Finland

recurrent infarction in diaphragmatic wall unspecified coronary artery status

17.7

71.4

WX892

NOMESCO Finland

Monitored bed care

2.0

71.0

788

4043

I21.97

ICD-10 Finland

Suspected acute myocardial infarction

4.1

70.5

199

499

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.5

70.4

4191

33521

A02BC02

ATC

pantoprazole; systemic

1.5

69.5

5375

45350

TPH07

NOMESCO Finland

Cathetrisation of artery

1.8

69.0

1140

6676

A10AE04

ATC

insulin glargine; parenteral

1.9

68.9

981

5482

FN1CA

NOMESCO Finland

Optical coherence tomography of coronary arteries

5.9

68.5

124

214

R4110

NOMESCO Finland

Physiotherapy

1.6

67.8

2202

15420

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.8

67.2

1213

7288

Z2221

NOMESCO Finland

Medical doctor

1.6

66.5

2026

13965

FN2DB

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA) of coronary restenosis

8.8

66.4

Z3231

NOMESCO Finland

Registered nurse

1.6

66.3

2256

15954

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

2.2

64.8

554

2567

K75

ICPC

Acute myocardial infarction

7.4

64.7

129

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

2.5

64.5

426

1762

AA1

Conventional CABG

2.9

64.4

312

1103

FN1CC

NOMESCO Finland

Very extensive angiography of heart and/or coronary arteries

3.3

63.9

241

736

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.6

63.3

2244

15985

K74

ICPC

Ischaemic heart dis with angina

3.6

61.7

206

581

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

2.3

60.6

472

2102

C10AA03

ATC

pravastatin; oral

2.0

59.6

754

4042

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.5

58.7

2161

15473

FN1BB

NOMESCO Finland

Contrast angiography of heart and/or coronary arteries after bypass surgery

4.1

58.5

163

405

I47.2

ICD-10 Finland

Ventricular tachycardia

2.9

57.3

281

1000

C10AA04

ATC

fluvastatin; oral

1.8

56.3

915

5310

A10AB05

ATC

insulin aspart; parenteral

1.9

56.3

735

3980

TFC10

NOMESCO Finland

Catheterisation of left atrium or ventricle

3.2

56.1

227

724

C10AX13

ATC

evolocumab; parenteral

6.1

55.3

159

C10AA07

ATC

rosuvastatin; oral

1.5

55.2

2555

19139

H3603, E103,

ICD-10 Finland

6.1

54.9

157

Z3226

NOMESCO Finland

Physiotherapist

1.6

54.5

1404

9234

A10AA02, ,

ATC

2.5

53.5

345

1410

ZXE00

NOMESCO Finland

One hour or less

1.5

53.5

2826

21692

FNC10

NOMESCO Finland

Aorto-coronary venous bypass with single distal anastomosis

3.3

53.1

203

625

WX890

NOMESCO Finland

Intesive care monitoring

4.6

52.8

126

278

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

3.2

52.5

212

675

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.6

51.9

1373

9078

TPH04

NOMESCO Finland

Cathetrisation of vein

1.5

51.6

1849

13104

FXG00

NOMESCO Finland

Insertion and use of IABP

8.6

50.2

I21.22

ICD-10 Finland

Acute transmural myocardial infarction with other coronary artery localization

+∞

49.0

I20.91

ICD-10 Finland

Angina pectoris, unspecified

3.1

48.3

206

678

AP1

Catheterization of the left side of the heart

3.0

47.4

215

733

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

45.1

5452

47836

I49.0

ICD-10 Finland

Ventricular fibrillation and flutter

3.7

43.6

141

390

T90

ICPC

Diabetes non-insulin dependent

1.4

43.5

2151

16168

R07.3

ICD-10 Finland

Other chest pain

1.7

43.1

815

4924

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.7

42.4

843

5163

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

1.8

41.3

609

3418

XFN00

NOMESCO Finland

Inside imaging of coronary arteries??

4.1

41.1

114

283

A10AB01

ATC

insulin (human); parenteral

2.4

40.6

280

1180

C01BD01

ATC

amiodarone; systemic

2.2

39.5

333

1530

A10AA01, ,

ATC

2.8

39.2

199

722

FN2CD

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA) of vein graft

8.5

39.0

FN2CB

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA) of coronary chronic total occlusion

4.1

38.7

108

269

I21.28

ICD-10 Finland

Acute transmural myocardial infarction with different localization different occlusion in coronary artery

+∞

38.6

A10BK03

ATC

empagliflozin; oral

1.6

38.4

883

5611

FN1XT

NOMESCO Finland

Other coronary artery procedure through catheter

4.3

37.5

224

111

Conventional CABG

3.4

37.0

132

390

I20.19

ICD-10 Finland

Angina angiospastic

5.6

36.6

124

ZX120

NOMESCO Finland

Intravenous

1.7

36.0

726

4457

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.7

35.7

662

3971

FNC40

NOMESCO Finland

Aorto-coronary venous bypass with four distal anastomoses

3.4

35.3

130

392

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.4

34.7

243

1032

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.4

34.4

1903

14490

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

4.5

34.2

190

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.3

33.8

265

1182

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.6

33.7

765

4839

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

2.3

33.6

257

1134

I21.02

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

9.3

33.5

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

2.6

33.5

192

742

A11

ICPC

Chest pain NOS

1.7

33.5

683

4203

M01AH05

ATC

etoricoxib; oral

0.7

33.2

2779

33460

PEF23

NOMESCO Finland

Thrombendarterectomy of femoral artery

2.5

32.9

207

837

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

3.0

32.6

147

500

1CX08, ,

NOMESCO Finland

4.8

32.4

150

A10AE05

ATC

insulin detemir; parenteral

1.9

32.0

445

2449

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

2.4

31.8

228

978

A10AB04

ATC

insulin lispro; parenteral

2.4

31.8

218

917

TK800

NOMESCO Finland

Hemodialysis

2.4

31.7

211

876

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.8

31.6

527

3066

I20.0

ICD-10 Finland

Unstable angina

3.2

31.5

126

400

A10BB12

ATC

glimepiride; oral

1.6

31.3

754

4837

C08CA01

ATC

amlodipine; oral

1.3

31.2

3352

28175

XF600

NOMESCO Finland

Bloodpressure measurement

1.8

31.1

528

3086

FN2CC

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA) of left main trunk

3.3

30.8

118

365

WX900

NOMESCO Finland

Resuscitation

4.5

30.5

166

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

2.3

30.0

237

1061

FPG32

NOMESCO Finland

Implantation of cardioverter-defibrillator with atrial and ventricular electrodes

3.9

29.7

225

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

4.1

29.7

199

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.5

29.4

1006

6977

B01AC07

ATC

dipyridamole; systemic

1.7

29.2

584

3572

FNE20

NOMESCO Finland

Coronary bypass using free arterial graft of radial artery

3.7

29.0

247

I20.9

ICD-10 Finland

Angina pectoris, unspecified

2.7

29.0

160

607

ANE

Coronary internal ultrasound (IVUS)

5.0

28.6

123

XFE00

NOMESCO Finland

Epicardial ultrasonography

2.2

28.3

231

1049

TFN40

NOMESCO Finland

Catheterisation of heart with balloon widening of coronary vessels

4.9

28.3

128

WX730

NOMESCO Finland

Conventional respirator

2.6

28.1

159

611

N07BA03

ATC

varenicline; oral

2.1

27.6

272

1330

XF404

NOMESCO Finland

Ambulatory ECG

1.6

27.4

714

4660

I20.80

ICD-10 Finland

Other angina pectoris no detected stenosis of coronary artery

2.5

27.3

179

738

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.2

27.2

229

1053

FPG30

NOMESCO Finland

Implantation of cardioverter-defibrillator with ventricular electrode

3.9

27.2

208

B01AA03

ATC

warfarin; systemic

1.3

27.1

2071

16498

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

2.5

26.9

170

690

A11CC03

ATC

alfacalcidol; systemic

2.2

26.8

221

1008

386

Kela drug reimbursment

Ticagrelor 60 mg

75.4

26.8

I21.4

ICD-10 Finland

Acute subendocardial myocardial infarction

2.4

26.5

176

731

TFN50

NOMESCO Finland

Catheterisation of heart with application of stent

6.4

26.4

R2110

NOMESCO Finland

Giving the first information

1.9

26.3

356

1943

G93.1

ICD-10 Finland

Anoxic brain damage, not elsewhere classified

4.5

26.1

141

ZXE20

NOMESCO Finland

More than three and less than five hours

1.5

26.0

1050

7514

J01FF01

ATC

clindamycin; systemic

1.3

25.8

1843

14520

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

3.8

25.7

207

ZXD10

NOMESCO Finland

Scheduled procedure

1.3

25.3

2667

22181

381

Kela drug reimbursment

Combination product containing sacubitril and valsartan

2.9

25.0

114

391

I20.10

ICD-10 Finland

Angina angiospastic

4.1

25.0

167

C08CA07

ATC

nisoldipine; oral

2.5

24.9

161

660

250, ,

Kela drug reimbursment

2.2

24.8

210

969

C09AA04

ATC

perindopril; oral

1.7

24.7

464

2790

TKC20

NOMESCO Finland

Catheterisation of bladder

1.6

24.6

667

4391

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

2.8

23.9

120

434

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.4

23.8

1292

9729

WX930

NOMESCO Finland

Thepapeutic hypothermia

7.7

23.8

I20

ICD-10 Finland

Angina pectoris

2.4

23.7

170

731

K01

ICPC

Heart pain

2.6

23.7

138

539

I22.99

ICD-10 Finland

Recurrent infarction with unspecified location unspecified coronary artery status

5.3

23.7

FNA20

NOMESCO Finland

Anastomosis to coronary arteries from bilateral internal mammary arteries

4.9

23.6

104

205

Kela drug reimbursment

Chronic hypertension

1.3

23.6

2655

22215

C09DX04

ATC

valsartan and sacubitril; oral

2.8

23.5

115

410

N18.8

ICD-10 Finland

Other chronic renal failure

2.0

23.3

256

1302

N17.9

ICD-10 Finland

Acute renal failure, unspecified

1.7

23.3

434

2603

A10BK01

ATC

dapagliflozin; oral

1.6

23.2

629

4138

T89

ICPC

Diabetes insulin dependent

2.0

23.0

240

1199

PD3YT

NOMESCO Finland

Pelvic artery PTA with stent

2.7

22.9

126

478

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.4

22.8

1095

8072

289

Kela drug reimbursment

Combination product containing sacubitril and valsartan

2.7

22.6

120

447

AA2

Off pump CABG sternotomy

3.6

22.6

212

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.3

22.3

2338

19355

207

Kela drug reimbursment

Chronic arrhythmias

1.3

22.2

1560

12220

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

2.7

22.0

121

459

TPX22

NOMESCO Finland

Intravenous arterial thrombolysis

3.0

22.0

322

XPX08

NOMESCO Finland

Intraoperative flow measurement

2.7

21.5

115

431

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

1.7

21.0

357

2086

R23.8

ICD-10 Finland

Other and unspecified skin changes

0.7

21.0

809

11186

A10BB01

ATC

glibenclamide; oral

1.6

20.9

496

3164

FNC50

NOMESCO Finland

Aorto-coronary venous bypass with five distal anastomoses

4.9

20.8

FNA96

NOMESCO Finland

Other connection to coronary artery from internal mammary artery

4.3

20.8

124

R07.2

ICD-10 Finland

Precordial pain

2.2

20.6

178

828

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

2.2

20.6

168

764

I50

ICD-10 Finland

Heart failure

1.8

20.4

341

1983

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

2.2

20.4

165

747

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

1.8

20.4

334

1933

5CM18, ,

NOMESCO Finland

4.3

20.3

122

ANC

Coronary artery pressure measurement (FFR, fractional flow reserve)

2.9

20.2

316

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

2.4

20.0

140

596

PE1AT

NOMESCO Finland

Femoral artery PTA

2.4

19.9

137

579

ZXE30

NOMESCO Finland

More than five and less than seven hours

1.7

19.9

365

2179

PD5AD

NOMESCO Finland

CT of aorta

1.9

19.9

233

1213

I21.13

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

+∞

19.8

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.4

19.7

1063

7979

Z2446

NOMESCO Finland

Social worker

1.7

19.6

395

2419

I34.02

ICD-10 Finland

Mitralysis insufficiency caused by ischemia

6.8

19.5

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

2.9

19.5

312

I21.0

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

2.7

19.4

101

373

C10BA02

ATC

simvastatin and ezetimibe; oral, topical

2.6

19.1

113

445

PEN23

NOMESCO Finland

Plastic repair of femoral artery

2.7

19.1

101

376

NHQ40

NOMESCO Finland

Amputation of toe

2.1

19.1

185

901

O24.0

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent

7.5

19.1

I20.8

ICD-10 Finland

Other forms of angina pectoris

2.7

18.9

101

379

R06.0

ICD-10 Finland

Dyspnoea

1.3

18.8

2039

16886

TFP52

NOMESCO Finland

Ablation treatment of ventricular tachycardia due to structural heart defect

8.1

18.7

A02BC01

ATC

omeprazole; systemic

1.3

18.7

1997

16502

315

Kela drug reimbursment

Clopidogrel

2.4

18.6

124

517

WX722

NOMESCO Finland

PEEP

1.7

18.6

368

2244

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.6

18.5

429

2720

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.3

18.4

2107

17554

H28.0*E10.3

ICD-10 Finland

Other specified diabetes mellitus - Diabetic cataract

7.8

18.3

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.7

18.2

335

2002

I21.9

ICD-10 Finland

Acute myocardial infarction, unspecified

1.9

18.1

246

1345

FN2EA

NOMESCO Finland

Coronary rotablation

3.5

17.6

173

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.4

17.6

1017

7712

ZXE10

NOMESCO Finland

More than one and less than three hours

1.2

17.5

2461

20972

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

2.4

17.2

121

518

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

2.0

17.0

194

1003

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

1.5

16.9

498

3335

A10BH05

ATC

linagliptin; oral

1.5

16.9

465

3068

A98

ICPC

Health maint/preventive medicine

0.8

16.8

6091

64308

C08DB01

ATC

diltiazem; oral

1.5

16.7

524

3555

K92

ICPC

Atherosclerosis/periph vascular dis

2.2

16.7

135

613

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

2.3

16.7

128

569

H3600, E103,

ICD-10 Finland

3.3

16.6

185

E10.5

ICD-10 Finland

Type 1 diabetes mellitus, With peripheral circulatory complications

3.7

16.6

142

A12AA04

ATC

calcium carbonate; oral

2.2

16.5

134

610

I71.4

ICD-10 Finland

Abdominal aortic aneurysm, without mention of rupture

1.7

16.5

286

1684

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

2.9

16.3

249

H3601, E103,

ICD-10 Finland

3.5

16.3

158

177

Kela drug reimbursment

Insulin glargine 300 U / ml

2.2

16.2

130

588

M01AE01

ATC

ibuprofen; systemic, rectal

0.8

16.2

5339

57093

N18.0

ICD-10 Finland

End-stage renal disease

2.4

16.2

105

433

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

1.6

16.2

401

2584

SPAT1262

SPAT

Handing over of treatment supplies

1.3

16.1

1342

10716

TFN04, ,

NOMESCO Finland

3.0

16.0

225

I74.3

ICD-10 Finland

Embolism and thrombosis of arteries of lower extremities

2.4

16.0

109

460

XF409

NOMESCO Finland

Other special ECG

3.3

15.9

185

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

1.4

15.8

639

4556

AS7

Arrhythmia pacemaker insertion VVI (R) S

4.5

15.8

FN2DA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA) of stent thrombosis

33.4

15.7

A10AD01

ATC

insulin (human); parenteral

2.0

15.7

164

823

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

3.9

15.5

112

FXZ00

NOMESCO Finland

Off-pump cardiac operation

2.8

15.5

273

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.6

15.4

339

2123

Z72.0

ICD-10 Finland

Tobacco use

2.0

15.4

154

760

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

2.4

15.3

108

463

D64.9

ICD-10 Finland

Anaemia, unspecified

1.3

15.2

1017

7873

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.6

15.2

337

2115

A10AE06

ATC

insulin degludec; parenteral

1.8

15.2

211

1164

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

3.7

15.2

132

C10AA02

ATC

lovastatin; oral

1.6

15.2

377

2432

A12BA01

ATC

potassium chloride; oral

1.5

15.2

437

2914

PE1BT

NOMESCO Finland

Femoral artery extensive PTA

2.6

15.0

335

H36.00

ICD-10 Finland

Diabetic background retinopathy

2.3

15.0

109

474

L82

ICD-10 Finland

Seborrhoeic keratosis

0.7

14.9

727

9710

I22.10

ICD-10 Finland

recurrent infarction in the diaphragmatic wall no detected stenosis of coronary artery

10.8

14.9

A10BH01

ATC

sitagliptin; oral

1.4

14.9

748

5538

ZXE90

NOMESCO Finland

More than 22 hours

2.7

14.9

296

4120B

ICD-9 Finland

Old myocardial infarction[STATUS POST INFARCTUM CORDIS,AHTAUTUNUT]

2.1

14.8

133

630

L04AA06

ATC

mycophenolic acid; systemic

2.2

14.7

117

529

R57.0

ICD-10 Finland

Cardiogenic shock

5.8

14.4

I22.11

ICD-10 Finland

recurrent infarction in the diaphragmatic wall stenosed coronary artery

27.2

14.2

N02AX02

ATC

tramadol; systemic, rectal

1.2

14.2

3146

27923

PD5BD

NOMESCO Finland

Extensive CT of aorta

1.9

14.2

174

923

PD4AD

NOMESCO Finland

CT of lower extremity arteries

2.4

13.9

366

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.4

13.9

686

5066

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.2

13.8

2110

18049

M86.9

ICD-10 Finland

Osteomyelitis, unspecified

2.5

13.7

332

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

0.8

13.6

1482

17800

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.2

13.5

2421

21035

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

2.9

13.5

210

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.3

13.5

921

7147

C08CA05

ATC

nifedipine; systemic

1.4

13.5

522

3694

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.3

13.4

1232

9945

Z95.9

ICD-10 Finland

Presence of cardiac and vascular implant and graft, unspecified

3.7

13.4

115

Z49.2

ICD-10 Finland

Other dialysis

2.9

13.4

222

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

1.6

13.4

332

2143

C08CA02

ATC

felodipine; oral

1.3

13.3

818

6249

XCK10

NOMESCO Finland

Photography of fundus of eye

1.4

13.3

719

5387

I21.48

ICD-10 Finland

Acute subendocardial infarction other occlusion in coronary artery

4.5

13.3

B01AC05

ATC

ticlopidine; oral

6.3

13.3

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

2.4

13.2

387

WW200, ,

SPAT

0.8

13.2

1305

15853

FNA02

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, two distal anastamoses

3.5

13.0

127

A10AD05

ATC

insulin aspart; parenteral

1.8

13.0

185

1031

R55

ICD-10 Finland

Syncope and collapse

1.3

12.9

906

7055

C07AG02

ATC

carvedilol; oral

1.4

12.9

496

3506

M04AA01

ATC

allopurinol; systemic

1.3

12.9

1286

10484

H3603, E113,

ICD-10 Finland

2.4

12.8

337

H36.09*E11.3

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic retinopathy

2.6

12.8

278

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

2.6

12.8

284

K03.64

ICD-10 Finland

Dental calculus supragingival

0.8

12.8

995

12454

V03AE02

ATC

sevelamer; oral

3.3

12.8

148

J01MA12

ATC

levofloxacin; systemic

1.3

12.8

1438

11886

XFP96

NOMESCO Finland

Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation

1.9

12.7

168

914

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

1.6

12.7

285

1797

FN1ST

NOMESCO Finland

Endovascular thrombolytic therapy of coronary arteries

32.1

12.6

2500A

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]

1.7

12.5

246

1500

I21.38

ICD-10 Finland

Acute transmural myocardial infarction with unspecified localization other occlusion in coronary artery

+∞

12.5

WX408

NOMESCO Finland

General anesthesy, balanced

1.2

12.4

1636

13755

I70.9

ICD-10 Finland

Generalized and unspecified atherosclerosis

1.7

12.3

199

1150

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

2.2

12.3

425

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.3

12.3

1033

8240

E78.29

ICD-10 Finland

Other mixed hyperlipidaemia

2.5

12.3

320

R03BB04

ATC

tiotropium bromide; inhalant

1.3

12.2

868

6768

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.4

12.2

508

3642

137

Kela drug reimbursment

Uraemia requiring dialysis

2.6

12.2

262

R11

ICD-10 Finland

Nausea and vomiting

1.4

12.1

519

3740

ANA

Coronary roablation

6.0

12.1

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.2

12.1

1508

12605

PDQ20

NOMESCO Finland

Insertion of endovascular graft into common iliac artery

2.9

12.0

191

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

0.7

12.0

428

6032

I20.88

ICD-10 Finland

Other angina pectoris other occlusion in coronary artery

3.2

12.0

144

M17.1

ICD-10 Finland

Other primary gonarthrosis

0.8

12.0

1019

12622

S82

ICPC

Naevus/mole

0.7

12.0

431

6065

I20.08

ICD-10 Finland

Unstable angina

3.8

12.0

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

1.7

11.9

200

1169

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.5

11.9

350

2346

PF1BT

NOMESCO Finland

Extensive PTA of arteries of knee, lower leg and ankle

2.5

11.9

289

L04AD02

ATC

tacrolimus; systemic

2.7

11.8

226

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.6

11.8

257

1608

M10.9

ICD-10 Finland

Gout, unspecified

1.4

11.8

649

4875

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

0.8

11.7

1061

13041

ZPB22

NOMESCO Finland

Autograft of vein

2.7

11.6

228

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

1.5

11.6

377

2579

127

Kela drug reimbursment

Transplant complication

2.2

11.6

410

B03XA02

ATC

darbepoetin alfa; parenteral

1.8

11.6

167

934

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.3

11.6

759

5851

I42.8

ICD-10 Finland

Other cardiomyopathies

3.2

11.6

137

TK810

NOMESCO Finland

Hemofiltration

2.7

11.5

212

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.3

11.5

1064

8585

296

Kela drug reimbursment

Rivaroxaban for the treatment of coronary heart disease

5.7

11.5

FNE01

NOMESCO Finland

Coronary bypass using free arterial graft of internal mammary artery, one graft

5.7

11.5

I21.23

ICD-10 Finland

Acute transmural myocardial infarction with other localization embolus in coronary artery

+∞

11.5

EBA15

NOMESCO Finland

Extraction of multiple teeth

1.6

11.4

291

1890

Z49.1

ICD-10 Finland

Extracorporeal dialysis

2.1

11.4

108

525

3025

Kela drug reimbursment

Calcium carbonate

2.8

11.3

192

FJA10

NOMESCO Finland

Transvenous biopsy of right ventricle

3.5

11.3

105

I51.4

ICD-10 Finland

Myocarditis, unspecified

3.5

11.2

110

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

1.4

11.2

442

3139

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

1.6

11.2

267

1709

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

3.7

11.2

I79.2*E11.5

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic peripheral angiopathy

2.9

11.1

183

XFL00

NOMESCO Finland

Cineangiography of left atrium and vetricle

4.1

11.1

4130B

ICD-9 Finland

Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),AHTAUTUNUT]

1.8

11.1

175

1006

6480A

ICD-9 Finland

Other current conditions in the mother classifiable elsewhere but complicating pregnancy, childbirth and the puerperium, Diabetes mellitus

8.0

11.0

I22.90

ICD-10 Finland

recurrent infarction with unspecified location no detected stenosis of coronary artery

8.0

11.0

B05DA

ATC

Isotonic solutions

2.7

11.0

223

J81

ICD-10 Finland

Pulmonary oedema

2.6

11.0

252

I21.98

ICD-10 Finland

Myocardial infarction (acute) UNS other occlusion in the coronary artery

5.7

11.0

I24.9

ICD-10 Finland

Acute ischaemic heart disease, unspecified

2.8

10.9

185

FP1C5

NOMESCO Finland

Resting ECG, 15 leads

2.2

10.9

421

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

1.8

10.9

144

785

4100X

ICD-9 Finland

Acute myocardial infarction, Of anterolateral wall[INFARCTUS MYOCARDII ACUTUS DEFINITUS,MÄÄRITTELEMÄT]

1.6

10.9

226

1399

PE1YT

NOMESCO Finland

Femoral or popliteal artery PTA with stent

2.2

10.9

415

G04BD12

ATC

mirabegron; oral

0.7

10.9

519

6968

WX213

NOMESCO Finland

Lower leg blockade

2.4

10.8

290

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

0.8

10.8

2212

25065

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

1.6

10.8

225

1396

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

1.6

10.7

276

1798

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.4

10.6

586

4408

Z50.1

ICD-10 Finland

Other physical therapy

1.5

10.5

325

2205

R04.0

ICD-10 Finland

Epistaxis

1.3

10.4

609

4615

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

2.9

10.4

168

TFN99

NOMESCO Finland

Catheterisation of heart with other coronary procedure

3.9

10.4

M01AX05

ATC

glucosamine; oral

0.8

10.3

904

11169

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.6

10.3

262

1705

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

1.5

10.2

300

2011

Z94.1

ICD-10 Finland

Heart transplant status

4.7

10.2

WX882

NOMESCO Finland

High dependency care

1.7

10.2

197

1199

H04AA01

ATC

glucagon; nasal, parenteral

2.1

10.1

414

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

1.7

10.1

171

1003

I44.2

ICD-10 Finland

Atrioventricular block, complete

1.5

10.1

266

1744

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.5

10.0

318

2168

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.2

10.0

1347

11328

B05DB

ATC

Hypertonic solutions

2.6

10.0

206

SDA03

NOMESCO Finland

Periodontal treatment

0.8

9.9

1554

18069

C09AA02

ATC

enalapril; systemic

1.2

9.8

1646

14137

Z49.0

ICD-10 Finland

Preparatory care for dialysis

2.2

9.8

380

D01BA02

ATC

terbinafine; oral

0.8

9.8

1282

15175

A10BJ06

ATC

semaglutide; parenteral

1.5

9.8

287

1925

L15

ICPC

Knee symptom/complaint

0.8

9.7

976

11880

I95.9

ICD-10 Finland

Hypotension, unspecified

1.8

9.7

135

750

3AC01, ,

NOMESCO Finland

2.4

9.7

269

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

2.3

9.6

300

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

3.1

9.6

127

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.5

9.5

274

1830

I22.89

ICD-10 Finland

recurrent infarction with other location unspecified coronary artery status

11.4

9.5

N19

ICD-10 Finland

Unspecified kidney failure

1.5

9.5

334

2323

4120X

ICD-9 Finland

Old myocardial infarction[STATUS POST INFARCTUM CORDIS,MÄÄRITTELEMÄT]

1.7

9.5

150

864

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

0.8

9.5

1822

20819

A41.9

ICD-10 Finland

Sepsis, unspecified

1.5

9.5

290

1962

N40

ICD-10 Finland

Hyperplasia of prostate

0.8

9.5

2051

23194

AA1AD

NOMESCO Finland

CT of head and brain

1.2

9.5

2272

20134

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

2.7

9.4

183

PBL09

NOMESCO Finland

Construction of arteriovenous fistula from brachial artery

3.7

9.4

FWD00

NOMESCO Finland

Reoperation for superficial haemorrhage in surgery of heart and major thoracic vessels

2.3

9.4

291

C03AA03

ATC

hydrochlorothiazide; oral

1.3

9.4

690

5403

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

1.5

9.4

263

1748

I21.32

ICD-10 Finland

Acute transmural myocardial infarction with unspecified coronary artery location

+∞

9.4

XF640, ,

NOMESCO Finland

1.6

9.3

208

1312

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

0.4

9.3

1211

SDA04

NOMESCO Finland

Demanding periodontal treatment

0.8

9.3

999

12079

N17.8

ICD-10 Finland

Other acute renal failure

1.9

9.3

107

559

H3601, E113,

ICD-10 Finland

1.8

9.3

125

687

R00.1

ICD-10 Finland

Bradycardia, unspecified

1.5

9.2

301

2064

C09AA01

ATC

captopril; oral

1.7

9.2

172

1038

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

1.6

9.2

234

1522

GD1LA

NOMESCO Finland

1.8

9.2

120

654

B04AC04, ,

ATC

2.3

9.2

307

L01BA01

ATC

methotrexate; systemic

1.6

9.2

192

1194

SAA02

NOMESCO Finland

Basic examination of mouth

0.9

9.1

3045

33323

E87.5

ICD-10 Finland

Hyperkalaemia

1.7

9.0

165

991

TFP00

NOMESCO Finland

Temporary use of transvenous or epicardial pacemaker

1.9

8.9

101

525

C10AB02

ATC

bezafibrate; oral

1.9

8.9

112

603

H02AB06

ATC

prednisolone; systemic

1.2

8.9

3322

30422

I65.2

ICD-10 Finland

Occlusion and stenosis of carotid artery

1.6

8.8

191

1197

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

0.7

8.8

302

4285

H3600, E113,

ICD-10 Finland

1.9

8.8

104

549

L04AX01

ATC

azathioprine; systemic

1.6

8.8

199

1262

E10

ICD-10 Finland

Type 1 diabetes mellitus

2.1

8.7

372

PD4HE

NOMESCO Finland

Postoperative lower extremity artery ultrasound examination with Doppler method

3.3

8.7

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.4

8.7

384

2784

OAB43, ,

SPAT

0.7

8.7

414

5563

C10AB05

ATC

fenofibrate; oral

1.8

8.7

121

673

R02

ICPC

Shortness of breath/dyspnoea

1.3

8.7

886

7227

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.2

8.6

2074

18356

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

2.4

8.6

252

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

1.4

8.6

432

3200

PD3AT

NOMESCO Finland

Pelvic artery PTA

2.4

8.6

222

PG5AC

NOMESCO Finland

Contrast examination of injection gate to artery or vein

4.8

8.6

C02DE04, ,

ATC

1.5

8.6

254

1710

EB4VA, ,

NOMESCO Finland

0.7

8.6

381

5172

S97

ICPC

Chronic ulcer skin

1.3

8.5

492

3723

K02

ICPC

Pressure/tightness of heart

1.7

8.5

147

869

PEN24

NOMESCO Finland

Plastic repair of deep femoral artery

2.8

8.5

142

SDA02

NOMESCO Finland

Periodontal treatment, brief

0.8

8.5

1379

16016

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

2.0

8.5

417

C07AA05

ATC

propranolol; systemic

0.8

8.4

604

7661

PEH56

NOMESCO Finland

Bypass from femoral to popliteal artery above knee

2.1

8.4

365

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

1.5

8.4

249

1678

I22.81

ICD-10 Finland

recurrent infarction with another location stenosed coronary artery

12.7

8.4

PG1AE

NOMESCO Finland

Ultrasound examination of artery not elsewher classified

2.7

8.3

166

V03AE01

ATC

polystyrene sulfonate; oral

1.8

8.3

114

631

I70.0

ICD-10 Finland

Atherosclerosis of aorta

2.3

8.3

250

H36.01

ICD-10 Finland

Diabetic maculopathy

1.9

8.3

482

SPAT1097

SPAT

Recording of ECG

1.2

8.3

1000

8305

I24.1

ICD-10 Finland

Dressler syndrome

4.1

8.2

A02BA02

ATC

ranitidine; systemic

1.2

8.2

1371

11756

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

1.4

8.2

308

2173

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.3

8.2

534

4117

I34.00

ICD-10 Finland

Mitral (valve) incompetence NOS or of specified cause, except rheumatic

1.6

8.1

161

989

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

1.5

8.1

232

1551

K22

ICPC

Risk factor cardiovascular disease

1.4

8.1

394

2905

PJA12

NOMESCO Finland

Sentinel node biopsy

0.6

8.1

129

2157

D62

ICD-10 Finland

Acute posthaemorrhagic anaemia

2.0

8.1

438

CKC12

NOMESCO Finland

Photocoagulation of retina

1.5

8.1

248

1683

PAF14

NOMESCO Finland

Thrombendarterectomy of internal carotid artery

1.7

8.1

137

808

G04CA01

ATC

alfuzosin; oral

0.8

8.1

917

11028

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.4

8.0

293

2055

I72.4

ICD-10 Finland

Aneurysm and dissection of artery of lower extremity

2.4

8.0

205

PEC23

NOMESCO Finland

Suture of common femoral artery

2.7

8.0

147

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

1.8

8.0

109

603

B01AF02

ATC

apixaban; oral

1.2

8.0

1106

9314

PEF24

NOMESCO Finland

Thrombendarterectomy of deep femoral artery

2.4

7.9

206

C01BC04

ATC

flecainide; systemic

0.5

7.9

1560

H02

ICPC

Hearing complaint

0.8

7.9

743

9120

M86.6

ICD-10 Finland

Other chronic osteomyelitis

2.8

7.8

132

ZXD35

NOMESCO Finland

Usual procedure

1.5

7.8

198

1290

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

1.4

7.8

361

2641

G63.2*E10.4

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic polyneuropathy

3.3

7.8

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

1.8

7.7

116

661

PWE00

NOMESCO Finland

Reoperation for deep haemorrhage in surgery of peripheral vessels and lymphatic system

2.5

7.7

179

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

2.5

7.7

185

R1420

NOMESCO Finland

Assessment of rehabilitation needs and/or compilation of rehabilitation plan

5.9

7.7

I25.40

ICD-10 Finland

Coronary artery aneurysm

7.4

7.7

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

2.6

7.6

157

C07AB08

ATC

celiprolol; oral

1.5

7.6

216

1444

E66.00

ICD-10 Finland

Metabolic syndrome

1.4

7.6

304

2172

V03AE03

ATC

lanthanum carbonate; oral

3.1

7.5

N03AX16

ATC

[U] pregabalin

1.2

7.5

1392

12038

J01DA01

ATC

[U] cefalexin

1.1

7.5

4122

38573

N083, E102,

ICD-10 Finland

7.1

7.5

D19

ICPC

Teeth/gum symptom/complaint

0.8

7.5

1071

12594

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.2

7.5

767

6260

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.3

7.5

494

3817

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

1.4

7.4

289

2052

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.3

7.4

625

4981

C09CA03

ATC

valsartan; oral

1.3

7.4

655

5251

E78.11

ICD-10 Finland

Other hypertriglyceridemia

2.5

7.4

171

4019X

ICD-9 Finland

Essential hypertension, Unspecified

1.4

7.4

271

1905

K08.3

ICD-10 Finland

Retained dental root

1.3

7.4

519

4043

N17.0

ICD-10 Finland

Acute renal failure with tubular necrosis

2.3

7.4

220

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

0.8

7.3

650

8037

ZXX02

NOMESCO Finland

Extent of procedure, 2 units

2.1

7.3

331

ZXE40

NOMESCO Finland

More than seven and less than nine hours

1.6

7.3

144

885

2507B

ICD-9 Finland

Diabetes mellitus, Diabetes with peripheral circulatory disorders[DIABETES MELLITUS CUM COMPLICAT ALIA ,TYYPPI I]

3.6

7.3

NGQ20

NOMESCO Finland

Amputation of lower leg

2.3

7.3

240

FNE96

NOMESCO Finland

Coronary bypass using other free arterial graft

3.5

7.2

N06DA02

ATC

donepezil; oral

0.7

7.2

331

4473

Q21.10

ICD-10 Finland

Persistent ostium secundum

3.8

7.2

K28

ICPC

Limited function/disability (K)

1.6

7.2

177

1146

H43.1

ICD-10 Finland

Vitreous haemorrhage

1.6

7.2

161

1022

Z94.0

ICD-10 Finland

Kidney transplant status

2.1

7.1

288

A10BX01

ATC

guar gum; oral

1.4

7.1

277

1970

FQA10

NOMESCO Finland

Orthotopic transplantation of heart with bicaval anastomosis

7.9

7.1

742, ,

NOMESCO Finland

3.3

7.1

R95

ICPC

Chron obstructive pulmonary disease

1.5

7.1

231

1589

NFQ20

NOMESCO Finland

Amputation of femur

1.9

7.1

432

C10AX16

ATC

inclisiran; systemic

8.8

7.0

4130X

ICD-9 Finland

Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),MÄÄRITTELEMÄT]

1.5

7.0

189

1249

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

0.8

7.0

843

10090

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

0.8

7.0

1158

13452

SAD01

NOMESCO Finland

Assessment of need for oral health care, standard

0.7

7.0

381

5015

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.4

7.0

306

2220

25008

ICD-8 Finland

Diabetes mellitus, Complicatio alia definita

3.9

7.0

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

1.7

7.0

109

630

DFF00

NOMESCO Finland

Pure tone audiometry

0.8

7.0

439

5661

A46

ICD-10 Finland

Erysipelas

1.2

7.0

1135

9704

I97.0

ICD-10 Finland

Postcardiotomy syndrome

2.6

6.9

141

D82

ICPC

Teeth/gum disease

0.8

6.9

1382

15801

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

1.4

6.9

264

1871

T81.7

ICD-10 Finland

Vascular complications following a procedure, not elsewhere classified

2.8

6.9

119

PB1DE

NOMESCO Finland

Upper extremity arteries ultrasound examination with Doppler method

2.9

6.9

108

Z01.2

ICD-10 Finland

Dental examination

0.9

6.9

1903

21223

C10AB04

ATC

gemfibrozil; oral

1.9

6.9

415

H02AB07

ATC

prednisone; oral

1.2

6.8

850

7081

FPJ21

NOMESCO Finland

Revision of cardioverter-defibrillator with ventricular electrode

4.1

6.8

A02BC03

ATC

lansoprazole; oral

1.2

6.8

1895

16918

N05CF01

ATC

zopiclone; oral

1.1

6.7

2279

20624

H91.1

ICD-10 Finland

Presbycusis

0.7

6.7

363

4783

H34.2

ICD-10 Finland

Other retinal artery occlusions

2.2

6.7

255

L57.0

ICD-10 Finland

Actinic keratosis

0.8

6.7

571

7093

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.2

6.7

1070

9131

PEF25

NOMESCO Finland

Thrombendarterectomy of superficial femoral artery

2.2

6.7

243

SDA01

NOMESCO Finland

Periodontal treatment, very brief

0.8

6.6

925

10915

FNE21

NOMESCO Finland

Coronary bypass using free arterial graft of radial artery sequential

2.8

6.6

116

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.3

6.6

511

4032

C01AA05

ATC

digoxin; systemic

1.2

6.5

821

6844

K05.31

ICD-10 Finland

Periodontitis pronounced

1.2

6.5

679

5548

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.5

6.5

208

1425

L40.0

ICD-10 Finland

Psoriasis vulgaris

1.4

6.5

231

1615

SPAT1043

SPAT

Audiometry

0.8

6.4

462

5860

PEH57

NOMESCO Finland

Bypass from femoral artery to popliteal artery below knee

1.9

6.4

375

3013

Kela drug reimbursment

Rivaroxaban for the treatment of coronary artery disease

3.5

6.4

XPX00

NOMESCO Finland

Intraoperative angiography

2.4

6.4

171

PEN25

NOMESCO Finland

Plastic repair of superficial femoral artery

2.5

6.4

147

A07EC01

ATC

sulfasalazine; oral, rectal

1.3

6.4

408

3139

4111X

ICD-9 Finland

Other acute and subacute forms of ischaemic heart disease, Intermediate coronary syndrome[PITKITTYNYT ANGINA PECTORIS -KOHTAUS,MÄÄRITTELEMÄT]

1.8

6.4

520

ZXC96

NOMESCO Finland

Robot assisted procedure

0.5

6.3

1119

I20.11

ICD-10 Finland

Angina angiospastic

4.1

6.3

E66.8

ICD-10 Finland

Other obesity

1.5

6.3

185

1248

K77

ICPC

Heart failure

1.5

6.3

200

1371

WW500

NOMESCO Finland

Blood transfusion

1.4

6.3

251

1795

FXF00

NOMESCO Finland

Decannulation after ECHLA or ECLA

9.2

6.3

SFA20

NOMESCO Finland

Two-surface restoration

0.9

6.3

2673

29011

5315

FHL

Bypass surgery using a mammary artery

1.7

6.3

106

627

E78.10

ICD-10 Finland

Familial hypertriglyceridemia

3.3

6.3

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

1.4

6.3

237

1679

NG1AA, ,

SPAT

0.6

6.2

138

2129

R4120

NOMESCO Finland

Occupational therapy

1.3

6.2

350

2644

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.3

6.2

438

3415

TFN10

NOMESCO Finland

Catheterisation of heart with local thrombolysis

26.7

6.2

ZXE60

NOMESCO Finland

More than 12 and less than 15 hours

2.1

6.2

257

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

1.3

6.2

341

2568

PDH54

NOMESCO Finland

Bypass from aorta to bilateral femoral arteries

3.1

6.1

K55.0

ICD-10 Finland

Acute vascular disorders of intestine

2.0

6.1

312

KA1AE

NOMESCO Finland

Kidney ultrasound examination

1.5

6.1

169

1125

SPAT1081

SPAT

Cardiorespiratory global assessment

1.3

6.1

375

2869

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.2

6.1

1013

8671

N06DA03

ATC

rivastigmine; oral, transdermal

0.7

6.1

220

3084

CKC15

NOMESCO Finland

Panretinal photocoagulation

2.0

6.0

307

K29.8

ICD-10 Finland

Duodenitis

2.0

6.0

321

2505A

ICD-9 Finland

Diabetes mellitus, Diabetes with ophthalmic manifestations[NEUROPATHIA DIABETICA,TYYPPI II]

2.9

6.0

I23.2

ICD-10 Finland

Ventricular septal defect as current complication following acute myocardial infarction

10.0

6.0

I20.02

ICD-10 Finland

Unstable angina

6.7

6.0

SPAT1104

SPAT

Monitoring of emergency patient

1.3

6.0

403

3122

Z3229

NOMESCO Finland

Other healthcare associate professional

1.3

6.0

544

4378

N02AJ06

ATC

codeine and paracetamol; systemic

1.1

6.0

2483

22733

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2550

15425

1.94

154.13

7.1

4.4

3119.58

421.61

ng/l

27.67

2406

13434

(3018677) aPTT in Platelet poor plasma by Coagulation assay

2144

12466

1.97

143.89

2.4

2.0

32.45

30.04

27.23

2095

12102

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

3777

26737

1.76

131.65

4.3

3.4

2587.51

1862.79

ng/l

8.83

3490

23351

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1444

7705

2.06

120.94

3.1

2.4

15.26

7.21

ug/l

10.01

1300

6662

(3032080) INR in Blood by Coagulation assay

4818

37848

1.65

103.59

20.2

19.9

1.36

1.37

inr

1.20

4135

32079

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

3868

29909

1.55

79.90

6.8

4.4

276.18

78.90

ng/l

11.67

3323

23875

(3003396) Base excess in Arterial blood by calculation

1647

10362

1.74

78.93

8.8

7.3

0.46

0.93

mmol/l

4.31

1354

8380

(3027801) Oxygen [Partial pressure] in Arterial blood

1651

10452

1.72

77.16

8.9

7.4

11.59

11.87

kpa

1.56

1592

9980

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1651

10455

1.72

77.06

8.9

7.4

4.99

5.05

kpa

1.84

1589

10001

(3019977) pH of Arterial blood

1637

10409

1.71

75.03

9.0

7.4

7.41

7.42

0.63

919

5806

(3016502) Oxygen saturation in Arterial blood

1505

9392

1.74

73.67

9.1

7.6

95.00

95.27

0.76

1459

9042

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1382

8571

1.74

68.68

9.7

8.2

120.43

120.93

g/l

0.39

1357

8371

(3013826) Glucose [Moles/volume] in Serum or Plasma

5103

42884

1.50

64.75

7.6

5.5

7.38

6.93

mmol/l

34.52

4941

41038

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1797

12368

1.58

58.15

3.4

2.8

19.68

21.99

13.55

1703

11410

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1902

13292

1.56

57.47

3.4

2.7

2.23

g/l

0.10

1785

12195

(3020779) Urea [Moles/volume] in Serum or Plasma

1281

8258

1.65

53.84

9.9

7.0

12.06

11.41

mmol/l

2.07

1201

7815

(3022948) Iron [Moles/volume] in Serum or Plasma

1972

14099

1.52

53.01

3.4

2.7

11.05

12.20

umol/l

11.67

1861

13010

(3004451) EKG impression Narrative

176

504

3.55

51.59

1.5

1.2

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

618

3253

1.97

51.27

3.1

2.9

0.33

0.34

iu/ml

0.14

367

1807

(3012544) pH of Venous blood

1362

9135

1.59

48.17

5.4

3.8

7.37

7.38

1.87

885

5437

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1140

7323

1.65

48.15

4.1

3.3

369.64

254.66

ng/l

5.25

1060

6714

(3000991) Gas panel - Venous blood

1153

7432

1.64

48.03

11.0

8.7

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

917

5582

1.72

47.43

10.8

9.6

0.61

0.63

0.70

909

5540

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

933

5755

1.70

45.89

10.4

9.3

1.34

1.32

0.34

924

5713

(3014007) Fractional oxyhemoglobin in Arterial blood

928

5744

1.69

45.01

10.8

9.5

93.67

93.77

0.18

928

5719

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1319

8991

1.56

43.00

5.2

3.8

5.78

5.81

kpa

0.56

1279

8754

(3002032) Base excess in Venous blood by calculation

1290

8753

1.56

42.91

5.3

3.8

1.38

1.73

mmol/l

2.60

1105

7562

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

865

5342

1.69

42.17

10.5

9.2

23.62

24.22

mmol/l

6.33

841

5166

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

825

5058

1.70

41.29

12.0

9.8

15.91

15.95

0.17

806

4881

(3008152) Bicarbonate [Moles/volume] in Arterial blood

894

5611

1.67

40.93

8.2

6.7

24.06

24.35

mmol/l

1.42

858

5374

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1766

13001

1.46

39.22

3.8

3.3

0.82

0.81

mmol/l

0.33

1671

12155

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2938

23882

1.36

35.81

2.6

2.3

226.18

241.07

u/l

0.57

2775

22517

(3014111) Lactate [Moles/volume] in Serum or Plasma

1142

7845

1.53

35.35

9.3

7.4

1.43

1.38

mmol/l

0.63

1116

7637

(3023368) Bacteria identified in Blood by Culture

2983

24451

1.34

33.89

5.2

4.6

—

(3020682) Albumin/Creatinine [Ratio] in Urine

3144

26171

1.32

31.43

4.5

4.3

15.06

9.69

mg/mmol

5.01

2105

17110

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

823

5390

1.58

31.30

10.1

7.9

24.30

24.71

mmol/l

2.76

818

5340

(3024354) Oxygen [Partial pressure] in Venous blood

1074

7495

1.50

30.51

4.2

3.2

4.47

4.43

kpa

0.18

1036

7272

(3012516) Albumin [Mass/volume] in Urine

3036

25485

1.30

27.42

3.8

3.6

77.84

55.15

mg/l

4.25

2139

17254

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1441

10907

1.39

26.01

8.3

6.1

1.08

1.04

mmol/l

5.93

1339

10132

(3004119) Hemoglobin [Mass/volume] in Venous blood

810

5518

1.52

25.60

4.6

3.4

124.92

128.15

g/l

3.76

784

5357

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2527

20918

1.30

24.67

2.7

2.4

3.12

2.95

mg/l

2.31

2189

17892

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

744

5022

1.53

24.51

5.5

3.8

23.38

24.08

mmol/l

7.52

725

4948

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1802

14243

1.34

24.47

2.1

1.8

1.60

1.55

mg/l

0.24

1494

11282

(3033658) Prothrombin time (PT) actual/Normal

2213

18066

1.31

23.79

5.6

4.5

81.35

82.46

1.30

2166

17698

(3009508) Creatinine [Moles/volume] in Urine

3042

25906

1.28

23.45

3.7

3.5

7.39

7.70

mmol/l

3.85

2536

21557

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

4254

37881

1.25

21.86

7.1

6.8

12.73

12.90

umol/l

0.37

4090

36099

(3007930) Methemoglobin/Hemoglobin.total in Blood

570

3734

1.57

21.44

7.1

5.2

0.88

0.86

0.62

551

3533

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

506

3225

1.61

21.39

3.0

2.2

554.43

697.65

ug/l

0.58

489

3084

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

3642

31951

1.25

21.03

3.2

3.0

—

estimate

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2553

21501

1.27

20.93

3.4

3.3

39.75

36.85

u/l

0.73

2394

20160

(3027273) Bicarbonate [Moles/volume] in Venous blood

621

4168

1.53

20.92

4.6

3.6

24.97

25.04

mmol/l

0.19

602

4031

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

607

4089

1.52

20.09

6.9

4.9

1.70

1.59

1.78

590

3878

(3018405) Lactate [Moles/volume] in Arterial blood

459

2910

1.61

19.83

4.4

4.0

1.54

1.44

mmol/l

0.77

448

2858

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1408

11037

1.33

19.71

1.9

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

163

3.64

18.47

1.1

1.4

1.18

1.17

mmol/l

0.80

163

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

335

1996

1.71

18.43

2.8

2.4

3.51

3.64

g/l

0.85

325

1901

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1799

14719

1.28

18.17

2.1

2.0

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

573

3905

1.50

17.93

2.1

1.9

1.83

2.28

ug/l

0.59

524

3415

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1309

10281

1.32

17.91

2.0

1.9

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2691

30959

0.81

17.81

4.5

4.9

22.91

22.26

1.29

1384

16382

(3038071) Oxygen [Partial pressure] in Mixed venous blood

187

3.39

17.71

7.3

7.2

5.34

5.40

kpa

0.08

187

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1899

22663

0.79

17.35

3.2

3.4

0.84

0.81

ug/l

0.41

1383

15877

(3043409) Potassium [Moles/volume] in Arterial blood

383

2402

1.62

17.31

4.8

4.3

3.95

3.94

mmol/l

0.17

376

2374

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

222

3.13

17.05

7.5

7.3

6.06

5.94

kpa

0.54

187

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

647

4567

1.45

16.94

5.5

4.2

44.51

46.65

1.46

635

4506

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

809

5953

1.40

16.79

1.7

—

(3028626) Oxygen [Partial pressure] in Capillary blood

358

2228

1.63

16.70

3.9

3.0

7.67

7.83

kpa

1.35

348

2169

(3015235) Bicarbonate [Moles/volume] in Capillary blood

484

3234

1.53

16.62

3.8

3.0

24.36

24.67

mmol/l

0.90

471

3173

(3027945) Reticulocytes/Erythrocytes in Blood

1368

10928

1.30

16.42

2.6

2.4

1.88

1.76

3.03

1225

9608

(3021901) Oxygen saturation in Capillary blood

323

1970

1.67

16.31

4.0

3.0

87.97

88.91

1.47

313

1911

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

636

4515

1.44

16.14

1.6

1.7

1.70

1.54

g/l

3.85

557

3852

(3044640) Blood type and Crossmatch panel - Blood

2673

23163

1.23

15.90

3.1

2.7

—

(40768804) Tissue Pathology biopsy report

2184

25433

0.81

15.57

2.2

2.3

—

(3042733) HLA Ab [Presence] in Serum

188

3.15

14.86

4.5

5.0

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1048

8186

1.32

14.70

3.0

2.8

9.18

10.23

umol/l

0.88

933

7259

(3024928) Oxygen saturation in Venous blood

337

2145

1.60

14.37

4.7

2.8

60.23

60.36

0.04

317

2052

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

3486

38522

0.84

13.86

5.3

6.0

3.16

3.67

ug/l

0.67

3083

34622

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

300

1877

1.62

13.75

2.8

2.2

85.33

88.14

1.28

295

1815

(3002582) Erythrocytes [#/volume] in Urine

2900

25608

1.20

13.70

4.1

3.8

171.08

105.74

e6/l

1.02

2321

20158

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

209

1203

1.76

13.11

6.1

6.4

12.09

12.10

mg/l

0.02

198

1095

(3036489) Thrombin time

360

2392

1.53

12.73

2.5

2.0

22.09

21.45

0.97

330

2180

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

719

5446

1.35

12.38

1.8

—

(3018572) Chloride [Moles/volume] in Blood

284

1803

1.60

12.29

9.1

6.6

105.13

105.09

mmol/l

0.05

263

1613

(3039000) Anion gap in Blood by calculation

284

1803

1.60

12.29

9.1

6.6

11.84

11.37

mmol/l

1.28

263

1613

(3006576) Bicarbonate [Moles/volume] in Blood

302

2.50

12.29

7.9

6.6

25.60

24.79

mmol/l

1.09

266

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

275

1733

1.61

12.27

2.9

2.5

225.13

208.79

2.01

268

1642

(3018095) Leukocytes [#/volume] in Urine

3085

27631

1.19

11.96

4.8

4.4

126.16

116.66

e6/l

0.15

2365

20692

(3030467) Casts [#/volume] in Urine by Automated count

2502

22018

1.20

11.83

4.0

3.7

0.69

0.48

e6/l

2.16

1947

16758

(3040151) Glucose [Moles/volume] in Capillary blood

181

1031

1.77

11.82

12.1

13.5

8.14

7.41

mmol/l

1.68

149

849

(3000850) Epithelial cells [#/volume] in Urine

2098

18170

1.21

11.79

3.2

2.9

4.68

3.89

e6/l

2.40

1940

16594

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

152

3.10

11.63

8.5

6.5

10.34

10.41

0.07

152

(3038515) Glucose [Moles/volume] in Venous blood

296

1933

1.55

11.36

4.8

3.6

7.98

7.78

mmol/l

0.58

291

1883

(3020891) Body temperature

552

4081

1.38

11.08

5.5

4.6

36.88

36.91

°c

0.70

547

4032

(3047181) Lactate [Moles/volume] in Blood

373

2577

1.47

10.95

8.2

5.7

1.50

1.34

mmol/l

1.35

339

2285

(1616796) Gas panel - Central venous blood

302

2005

1.53

10.77

5.4

3.9

—

(3007853) Bacteria identified in Skin by Aerobe culture

1075

8753

1.26

10.75

2.0

1.9

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

735

5732

1.31

10.32

5.4

4.1

128.14

99.57

ng/l

8.42

653

4860

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

760

5955

1.30

10.30

4.7

3.8

5.07

5.14

kpa

1.39

727

5632

(3023183) Ammonium ion [Moles/volume] in Plasma

278

1833

1.53

10.26

2.5

31.56

33.66

umol/l

0.82

245

1606

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

662

5099

1.32

10.16

4.6

3.6

1.70

1.83

mmol/l

0.34

481

3684

(3026250) Tacrolimus [Mass/volume] in Blood

258

2.45

10.04

41.3

37.6

7.45

7.35

ug/l

0.16

229

(36304419) Bacteria [Presence] in Urine

2332

20635

1.18

9.99

3.9

3.6

26.42

369.18

estimate

0.72

116

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

3692

33897

1.16

9.86

9.6

7.0

1.19

1.20

mmol/l

12.62

3475

31152

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

6347

65930

0.84

9.77

42.0

30.7

39.53

39.95

6.47

6266

64895

(3000963) Hemoglobin [Mass/volume] in Blood

6348

65939

0.84

9.76

41.1

30.4

132.03

134.13

g/l

19.33

6276

64963

(3035941) MCH [Entitic mass]

6347

65928

0.84

9.75

40.6

30.0

30.46

30.55

3.38

6264

64925

(3026361) Erythrocytes [#/volume] in Blood

6348

65931

0.84

9.70

40.7

30.1

4.38

4.43

e12/l

8.44

6179

64019

(3017446) Testosterone [Moles/volume] in Serum or Plasma

599

7746

0.76

9.70

2.2

2.3

11.96

12.93

nmol/l

1.91

510

6870

(3024731) MCV [Entitic mean volume] in Red Blood Cells

6348

65929

0.84

9.69

40.6

30.0

91.95

91.86

0.78

6267

64924

(3006442) Creatine [Moles/volume] in Serum or Plasma

449

2.06

9.66

1.6

1.8

108.10

97.43

umol/l

0.51

449

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

205

1279

1.62

9.62

1.5

1.4

—

(3007461) Platelets [#/volume] in Blood

6348

65919

0.84

9.61

40.7

30.1

233.59

235.35

e9/l

1.28

6201

64271

(3010813) Leukocytes [#/volume] in Blood

6351

65940

0.84

9.55

40.8

30.1

7.64

7.00

e9/l

21.33

6187

64034

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

4069

37704

1.16

9.43

10.4

7.7

1.20

1.21

mmol/l

16.86

3596

32331

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

236

1533

1.56

9.35

1.4

1.3

—

(3052851) Hemolysis interference index of Serum or Plasma

310

2138

1.47

9.24

4.3

3.8

1.79

1.93

index

0.24

182

1133

(3008037) Lactate [Moles/volume] in Venous blood

327

2283

1.45

9.15

4.7

3.4

1.63

1.67

mmol/l

0.33

321

2225

(3026008) Bacteria identified in Urine by Culture

2486

22243

1.17

9.11

3.7

3.6

—

(3009343) pH of Capillary blood

731

5795

1.29

9.06

4.7

3.8

7.41

7.42

0.67

637

4829

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

270

1819

1.50

9.05

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

270

1819

1.50

9.05

1.4

1.3

—

(3000330) Specific gravity of Urine by Test strip

527

3998

1.34

8.99

4.3

3.7

1.02

ratio

0.10

482

3641

(40767503) Oxygen content in Capillary blood by calculation

273

1846

1.50

8.99

3.8

2.7

15.80

16.08

0.73

267

1805

(3001122) Ferritin [Mass/volume] in Serum or Plasma

3165

28862

1.16

8.98

3.9

3.1

168.50

171.48

ug/l

0.19

2948

26371

(3006184) Hemoglobin [Mass/volume] in Capillary blood

303

2094

1.46

8.95

3.1

2.3

125.49

127.80

g/l

0.76

246

1621

(3023520) Reticulocytes [#/volume] in Blood

1037

8589

1.24

8.84

2.6

2.5

72.17

67.60

e9/l

2.95

753

6442

(3006504) Eosinophils/Leukocytes in Blood

3461

31818

1.15

8.68

7.2

6.3

2.88

2.86

0.14

3256

29602

(3022096) Basophils/Leukocytes in Blood

3459

31814

1.15

8.59

7.3

6.5

0.60

0.64

4.04

3256

29600

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

3090

28202

1.15

8.54

4.1

3.8

—

1.23

—

(3026782) Osmolality of Urine

1793

15700

1.18

8.48

3.5

3.2

541.64

549.26

mosm/kgh2o

0.87

1612

13839

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1586

13743

1.19

8.47

3.4

1.20

1.08

e6/l

0.54

908

7720

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

584

4539

1.31

8.41

1.5

—

(3019069) Monocytes/Leukocytes in Blood

3464

31896

1.15

8.40

7.4

6.5

9.20

9.25

0.47

3251

29663

(3024561) Albumin [Mass/volume] in Serum or Plasma

3656

33835

1.14

8.14

6.1

5.3

33.73

34.58

g/l

14.47

3438

31495

(3006315) Basophils [#/volume] in Blood

3712

34407

1.14

8.04

6.9

6.0

0.05

0.04

e9/l

0.61

3134

29151

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1230

10467

1.21

7.98

4.1

4.3

264.77

245.68

u/l

2.58

1172

9860

(3001604) Monocytes [#/volume] in Blood

3695

34267

1.14

7.89

6.9

6.0

0.68

0.64

e9/l

17.80

3111

28983

(3002030) Lymphocytes/Leukocytes in Blood

3499

32332

1.14

7.89

7.3

6.4

23.72

25.44

16.11

3318

30438

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

272

3853

0.70

7.88

2.2

3.37

3.58

ratio

1.38

223

3186

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

121

696

1.75

7.80

1.1

1.2

82.59

67.52

u/l

0.20

102

596

(3042936) Bacteria identified in Isolate by Culture

1306

11213

1.20

7.67

2.4

2.1

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1471

12766

1.19

7.65

3.6

3.5

2.35

1.58

e6/l

2.09

803

6719

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

283

1994

1.43

7.60

2.4

2.3

119.93

120.85

ug/min

0.01

179

1174

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

442

1.93

7.57

1.2

11.03

9.80

mmol/l

1.41

407

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

499

1.87

7.54

1.2

132.50

159.64

titre

0.15

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2536

22976

1.15

7.54

3.0

2.7

58.89

68.54

u/l

1.42

2378

21291

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1988

17704

1.16

7.47

3.0

2.6

—

(3019198) Lymphocytes [#/volume] in Blood

3755

34955

1.14

7.38

7.0

6.1

1.87

1.86

e9/l

0.08

3249

30282

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

174

2649

0.65

7.33

1.8

2.62

3.38

mmol/l

10.56

122

1963

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

301

2165

1.40

7.22

1.6

1.4

13.63

12.78

iu/ml

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

806

6664

1.23

6.96

2.9

2.5

41.78

46.53

u/l

0.26

709

5640

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

251

1764

1.44

6.87

1.5

1.4

—

(3013115) Eosinophils [#/volume] in Blood

3785

35353

1.13

6.86

7.1

6.2

0.22

0.20

e9/l

3.01

3261

30344

(3024891) Influenza virus A+B Ag [Presence] in Specimen

220

1509

1.47

6.85

1.2

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

417

1.90

6.77

1.3

1.5

17.39

14.60

umol/l

1.59

386

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

222

1531

1.46

6.73

1.5

1.4

—

(3027315) Oxygen [Partial pressure] in Blood

256

1814

1.42

6.71

5.9

4.5

8.36

8.40

kpa

0.18

250

1763

(3020564) Creatinine [Moles/volume] in Serum or Plasma

6350

65521

0.87

6.71

36.9

27.0

96.28

88.06

umol/l

25.27

6254

64519

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

6229

64354

0.87

6.68

15.8

13.1

27.74

26.41

u/l

3.39

6044

62059

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

121

2.73

6.68

11.1

12.3

5.19

5.38

mmol/l

0.17

121

(3012501) Base excess in Blood by calculation

255

1809

1.42

6.65

5.9

4.5

2.79

2.61

mmol/l

0.45

164

1210

(3013290) Carbon dioxide [Partial pressure] in Blood

255

1810

1.42

6.63

5.9

4.5

4.98

kpa

0.03

249

1760

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

173

1138

1.53

6.60

1.3

1.2

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

420

3234

1.31

6.53

1.6

1.5

5.83

20.48

iu/ml

3.35

(3044889) 12 lead EKG panel

4862

46189

1.13

6.51

6.2

4.7

0.70

1039.19

—

117

(3018010) Neutrophils/Leukocytes in Blood

3401

31634

1.13

6.47

7.3

6.3

60.74

58.98

13.97

3262

30021

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

156

1011

1.55

6.38

1.7

1.5

155.59

157.41

au/ml

0.06

303

(3017143) Hepatitis C virus Ab [Presence] in Serum

673

5513

1.24

6.34

1.8

1.6

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

220

1534

1.45

6.32

1.5

1.4

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

203

1398

1.46

6.23

1.6

1.5

1.03

0.86

nmol/l

1.46

159

1175

(3021589) Normoblasts [#/volume] in Blood

3115

28905

1.12

6.04

15.4

13.0

0.00

e9/l

1.08

2502

23477

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

739

6148

1.22

6.02

1.7

1.5

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

4062

38293

1.12

5.96

9.5

9.3

4.90

4.42

e9/l

24.56

3457

32926

(3024932) HLA-DR beta [Type]

165

2.37

5.94

1.0

1.1

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

357

2726

1.32

5.92

1.3

—

(3026493) Urate [Moles/volume] in Serum or Plasma

2195

19965

1.14

5.87

3.4

3.1

381.98

367.20

umol/l

7.47

1915

17284

(46235355) HIV 1 and 2 tests - Meaningful Use set

828

6995

1.20

5.76

1.7

1.6

—

(3017569) Oxygen content in Arterial blood

538

1.72

5.71

2.6

2.1

15.53

15.93

0.47

538

(3024471) HLA-A [Type]

169

2.31

5.65

1.0

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

238

3249

0.72

5.62

1.4

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

220

1574

1.41

5.54

1.2

1.3

29.80

35.85

u/l

0.51

196

1346

(21494755) Public health laboratory ask at order entry panel

210

2894

0.72

5.28

1.4

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

278

2085

1.34

5.26

1.5

1.6

—

(1761482) Bacteria [#/volume] in Urine by Culture

288

2174

1.34

5.22

5.5

4.3

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

412

3268

1.27

5.17

2.0

3.2

52.32

56.32

mg/l

0.13

345

2756

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

406

1.78

5.11

1.2

1.3

124.44

97.70

u/l

0.74

329

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

392

1.79

5.09

1.2

1.3

42.32

27.32

u/l

0.80

314

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

165

2351

0.70

5.06

1.7

1.9

42.77

43.73

nmol/l

0.23

156

2265

(3051611) Lipemic interference index of Serum or Plasma

119

768

1.56

5.05

4.6

3.8

11.76

12.18

index

0.30

421

(3034860) Kappa light chains.free [Mass/volume] in Serum

411

3272

1.27

5.02

2.0

3.2

89.19

76.79

mg/l

0.18

343

2761

(3036525) Urea [Moles/time] in 24 hour Urine

3.40

5.02

3.4

—

(3044242) Glucose [Moles/volume] in Arterial blood

536

1.67

5.01

2.1

1.9

9.52

8.01

mmol/l

1.75

536

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

103

644

1.61

5.01

1.2

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

352

2750

1.29

5.00

1.3

1.2

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

167

1165

1.44

4.88

1.7

1.4

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

374

2955

1.28

4.87

2.0

3.1

2.26

4.74

ratio

1.29

200

1737

(3022493) Free Hemoglobin [Mass/volume] in Plasma

354

1.81

4.86

8.0

4.9

3116.83

90.07

mg/l

0.48

245

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

201

1454

1.39

4.80

7.1

5.5

4245.51

1572.07

iu/ml

0.31

219

(3016750) Collection duration of Urine

460

1.70

4.77

2.3

2.1

506.16

496.27

min

0.37

328

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

376

2982

1.27

4.76

3.3

3.4

4.31

4.37

pmol/l

0.44

340

2628

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

293

2250

1.31

4.75

3.7

2.6

2.06

1.75

mg/l

5.41

261

1989

(3004775) Volume in Urine collected for unspecified duration

105

669

1.58

4.74

2.7

2.2

629.51

647.53

0.23

422

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

1003

0.56

4.72

1.2

0.59

0.65

ratio

0.47

176

(3020630) Protein [Mass/volume] in Serum or Plasma

878

7603

1.17

4.62

2.2

2.6

65.03

65.90

g/l

2.69

802

6860

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

3.49

4.60

4.3

2.9

—

(3018418) pH of Serum or Plasma

2427

22473

1.11

4.59

5.5

4.4

7.39

7.40

3.27

1810

16339

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

400

1.73

4.51

1.5

5.69

7.02

u/l

0.40

307

(21494890) Protein electrophoresis panel - 24 hour Urine

138

944

1.47

4.50

1.4

2.0

—

(3022313) Gas panel - Capillary blood

492

4051

1.23

4.49

4.7

3.9

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

4.82

4.49

3.8

11.1

104.69

105.15

g/l

0.04

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

5433

56177

0.90

4.46

5.3

4.9

2.05

2.04

mu/l

0.25

4960

50757

(40768800) Prostate Pathology biopsy report

195

2640

0.73

4.44

1.1

1.2

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

275

2115

1.31

4.43

1.6

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

586

1.59

4.43

1.5

1.4

—

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

130

883

1.48

4.40

1.1

—

17.93

u/ml

—

(3007566) Smooth muscle Ab [Titer] in Serum

223

1666

1.35

4.39

1.2

78.57

132.43

titre

1.56

148

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

140

966

1.46

4.38

1.4

1.2

273.14

293.82

u/ml

0.36

599

(4195642) Thrombophilia screening test

105

684

1.54

4.34

1.2

—

(3034770) Mitochondria Ab [Titer] in Serum

220

1644

1.35

4.33

1.2

1018.00

895.00

titre

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

306

2398

1.29

4.29

1.6

0.34

0.32

mg/l

0.29

152

1153

(3003434) Protein [Mass/volume] in Pleural fluid

210

1561

1.35

4.29

1.5

28.79

31.54

g/l

2.30

186

1393

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

308

2417

1.28

4.28

2.0

2.4

0.00

g/l

-0.00

287

2233

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

414

1.70

4.28

2.5

2.1

256.47

150.54

ug/min

0.40

106

(3021879) Hepatitis B virus core Ab [Presence] in Serum

450

3691

1.23

4.27

1.4

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

152

1074

1.42

4.21

1.5

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

154

1091

1.42

4.20

1.6

1.5

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

626

0.48

4.15

1.4

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

197

1459

1.36

4.13

1.6

1.7

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

228

1731

1.33

4.06

1.7

1.4

0.26

0.24

g/l

3.04

215

1642

(3002256) Pathology report gross observation

824

9420

0.86

4.01

1.3

1.4

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

261

2025

1.30

3.98

1.5

—

(3023419) Bacteria identified in Sputum by Culture

157

1128

1.40

3.98

2.3

2.4

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

5.56

3.97

6.2

6.0

341.50

451.56

umol/l

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

678

5827

1.18

3.93

3.5

2.8

51.72

61.56

ml/min/173m2

10.95

316

2579

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

234

1794

1.31

3.91

1.7

1.5

1.22

1.17

g/l

1.51

219

1703

(3027456) Digoxin [Moles/volume] in Serum or Plasma

273

2137

1.29

3.90

3.2

0.83

0.81

nmol/l

0.48

226

1675

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

157

1133

1.39

3.88

3.3

2.5

963.86

1652.52

u/ml

—

(4094501) Cardiovascular stress test using bicycle ergometer

241

1858

1.31

3.87

1.2

1.1

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

106

712

1.49

3.85

1.6

1.5

—

(3019309) Folate [Moles/volume] in Red Blood Cells

1676

15349

1.12

3.80

1.9

1.8

1095.52

1144.72

nmol/l

1.47

1326

11518

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

841

7389

1.15

3.68

2.2

0.19

0.20

g/l

0.88

779

6816

(3010421) pH of Blood

328

2647

1.25

3.66

5.7

4.1

7.41

0.79

323

2602

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

5.63

3.65

9.9

9.4

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

111

763

1.46

3.61

1.2

7.67

4.41

u/ml

0.68

371

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

299

1.74

3.57

2.7

2.2

102.25

95.05

0.70

288

(3000492) Spirometry study

645

5569

1.17

3.56

1.5

1.6

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

5739

58960

0.91

3.55

27.4

20.2

70.57

73.38

ml/min/173m2

18.59

5451

55328

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

392

3241

1.22

3.51

1.9

2.3

10.07

10.27

g/l

0.39

354

2837

(3013512) EKG study

2763

26025

1.09

3.50

5.9

4.1

0.86

0.77

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

107

737

1.46

3.47

1.3

0.21

0.20

nmol/l

0.54

609

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

138

1887

0.73

3.44

1.8

1.9

197.32

201.32

pmol/l

0.21

125

1755

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

330

2689

1.24

3.40

2.0

2.3

0.02

0.05

g/l

1.39

304

2389

(3001019) Free T4 and TSH panel - Serum or Plasma

1292

0.68

3.31

1.6

1.7

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

102

703

1.46

3.31

1.1

1.2

110.20

111.33

0.13

629

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

285

1.72

3.26

1.1

1.2

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

293

1.71

3.25

2.2

1.9

71.48

99.33

umol/l

1.16

155

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

130

942

1.39

3.21

1.0

1.1

12.48

252.18

iu/ml

0.71

175

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

123

884

1.40

3.19

1.1

—

(3023420) DNA double strand Ab [Units/volume] in Serum

279

2257

1.24

3.11

1.8

1.6

13.38

6.67

iu/ml

0.87

534

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

441

3736

1.19

3.09

1.8

2.3

3.79

3.75

g/l

0.27

406

3366

(3045788) Cell count panel - Pleural fluid

147

1097

1.35

3.04

1.4

1.5

—

(3037522) Nuclear Ab [Titer] in Serum

872

7787

1.13

3.03

1.4

1.3

514.17

472.71

titre

0.31

206

1646

(3014148) Varicella zoster virus Ab [Titer] in Serum

520

1.50

3.02

1.1

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

120

870

1.38

2.98

1.3

0.23

0.27

nmol/l

0.20

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

441

3749

1.19

2.98

1.8

2.3

4.13

4.15

g/l

0.33

406

3382

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

441

3749

1.19

2.98

1.8

2.3

7.79

7.38

g/l

5.66

406

3375

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

314

2587

1.22

2.96

2.0

2.3

0.00

g/l

1.04

287

2239

(4198724) Urine methamphetamine measurement

122

2.05

2.86

1.3

1.5

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

125

923

1.36

2.80

3.4

3.6

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

204

1615

1.27

2.77

3.8

3.7

29.55

31.29

mg/l

0.27

150

1164

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

531

1.47

2.76

1.6

1.5

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

606

1.44

2.74

1.3

1.2

19.63

61.96

u/ml

—

(3022145) Colonoscopy Study observation

687

7734

0.88

2.72

1.4

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

278

1.66

2.72

5.6

2.3

9.53

10.30

kpa

1.40

278

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

278

1.66

2.72

5.6

2.3

4.95

4.81

kpa

0.38

278

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

108

783

1.38

2.72

1.2

2.39

4.47

u/ml

1.17

277

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

367

3105

1.19

2.66

2.0

1.9

—

(3014051) Protein [Presence] in Urine by Test strip

1896

17756

1.09

2.64

3.7

3.2

0.06

0.08

0.15

604

(40768795) Lymph node Pathology biopsy report

680

0.62

2.58

1.2

—

(4035726) Immunohistochemistry procedure

539

6142

0.87

2.57

1.5

1.4

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

275

1.64

2.57

2.3

2.5

0.57

0.62

mmol/l

2.50

275

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

407

3485

1.18

2.57

1.9

2.4

3.14

2.91

g/l

4.72

370

3114

(3020491) Glucose [Moles/volume] in Blood

482

1.48

2.57

2.0

2.1

7.36

7.11

mmol/l

0.33

328

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

516

1.46

2.54

1.7

1.5

—

(3052592) Norovirus Ag [Presence] in Stool

164

1.83

2.52

1.7

1.4

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

781

7014

1.13

2.51

2.9

2.7

0.75

0.45

e6/l

1.32

760

6794

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

2.16

2.50

1.9

1.6

41.48

111.28

au/ml

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

511

1.45

2.47

1.0

1.2

—

(44790048) Parainfluenza type 2 nucleic acid detection

128

970

1.32

2.46

1.5

1.4

—

(44806118) Parainfluenza type 4 nucleic acid detection

128

970

1.32

2.46

1.5

1.4

—

(44790049) Parainfluenza type 3 nucleic acid detection

128

970

1.32

2.46

1.5

1.4

—

(44790047) Parainfluenza type 1 nucleic acid detection

128

970

1.32

2.46

1.5

1.4

—

(3036782) Glucose [Moles/volume] in Pleural fluid

139

1066

1.31

2.46

1.4

6.89

6.37

mmol/l

1.40

126

975

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

422

1.50

2.45

1.6

1.8

—

(3006270) Folate [Moles/volume] in Blood

629

1.40

2.44

1.2

320.63

327.09

nmol/l

0.09

487

(3022621) pH of Urine by Test strip

605

5358

1.14

2.44

2.9

5.94

6.02

1.42

461

3852

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

0.00

2.42

0.0

1.0

—

(40768806) Pleura Pathology biopsy report

150

1166

1.29

2.41

1.5

1.6

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

0.00

2.40

0.0

1.0

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

374

3201

1.18

2.40

1.9

2.4

0.73

1.02

g/l

0.79

326

2703

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

392

3368

1.17

2.40

2.2

2.0

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

264

2190

1.21

2.39

1.4

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

243

1.65

2.36

1.4

7.16

16.41

umol/l

1.34

165

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

892

8106

1.11

2.34

4.6

3.9

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

225

2735

0.82

2.34

1.2

1.3

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

6338

64501

0.93

2.33

35.7

25.0

4.06

4.02

mmol/l

28.96

6236

63075

(3019225) pH of Specimen

658

7349

0.89

2.33

5.4

4.6

7.35

7.36

0.14

515

5342

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2747

28756

0.93

2.33

2.6

2.3

75.30

78.31

nmol/l

6.72

2422

25315

(3020191) Ethanol [Moles/volume] in Serum or Plasma

535

1.42

2.31

1.2

1.3

1.19

1.17

promille

0.04

423

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

562

0.60

2.31

1.0

687.27

707.29

ng/l

0.09

377

(3001729) Color of Synovial fluid

2.31

1.5

1.3

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

561

0.60

2.30

1.0

49.01

41.41

ng/l

0.41

380

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

218

0.41

2.29

1.0

1.1

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

560

0.61

2.28

1.0

389.52

313.30

ng/l

0.59

386

(3013139) Helicobacter pylori Ag [Presence] in Stool

331

3873

0.85

2.27

1.3

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

5343

52146

1.07

2.25

9.7

8.6

86.53

82.44

u/l

3.34

5097

49326

(3045424) Erythrocytes [Presence] in Urine

303

3566

0.84

2.24

2.3

2.2

3.18

0.02

estimate

0.50

963

(3003129) Base excess in Capillary blood by calculation

134

1038

1.30

2.23

2.3

2.5

-0.27

0.21

mmol/l

0.70

124

995

(3018333) Ribosomal P Ab [Presence] in Serum

358

1.51

2.23

1.1

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

257

2146

1.20

2.20

1.4

1.5

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

214

1755

1.23

2.20

1.5

1.6

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

2.68

2.20

1.6

1.1

—

(40758558) Short blood count panel - Blood

2124

20121

1.07

2.17

7.6

6.5

—

(1617658) Protocol used for examination of sentinel lymph nodes

269

0.45

2.17

1.0

1.1

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

132

1025

1.29

2.17

1.2

42.75

44.66

u/ml

0.05

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

184

2263

0.81

2.17

1.0

1.1

—

(3010375) cycloSPORINE [Mass/volume] in Blood

265

1.59

2.16

26.7

29.0

102.39

113.09

ug/l

0.70

219

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

772

8504

0.90

2.16

6.1

5.3

33.54

32.76

1.21

625

5514

(3036481) Cortisol [Moles/volume] in Serum or Plasma

653

5862

1.12

2.15

2.6

2.4

393.73

382.29

nmol/l

0.36

602

5398

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

2.16

2.14

1.6

1.8

0.76

1.14

mmol/l

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

152

1205

1.27

2.13

1.2

—

1.02

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

724

1.34

2.11

1.3

—

nmol/l

—

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

167

1.74

2.10

1.6

1.5

18.71

8.73

1.23

(3011397) Hemoglobin [Presence] in Urine by Test strip

1759

16571

1.08

2.09

4.1

4.0

0.13

0.41

0.62

222

(3019550) Sodium [Moles/volume] in Serum or Plasma

6335

64395

0.93

2.07

35.4

24.8

139.38

139.58

mmol/l

7.53

6237

63050

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

2.32

2.04

1.2

1.6

—

(3005532) Lymphocytes/Leukocytes in Pleural fluid

399

1.46

2.03

1.6

1.4

59.86

66.73

0.84

322

(40768443) Skin Pathology biopsy report

273

3210

0.85

2.02

1.3

1.2

—

(3044007) Cell count panel - Peritoneal fluid

270

1.56

2.02

1.9

1.8

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

367

1.47

2.01

1.1

1.2

—

(40768446) Kidney Pathology biopsy report

247

1.58

2.00

1.7

1.6

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

724

1.33

1.98

1.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

503

1.39

1.95

2.2

2.3

26.47

29.88

iu/ml

—

(3000919) Neutrophils/Leukocytes in Pleural fluid

297

1.52

1.94

1.5

1.4

22.52

19.64

0.27

267

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

296

0.51

1.94

6.1

6.7

3.56

237.96

ug/l

—

189

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

149

1.75

1.94

1.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

693

1.33

1.92

2.2

2.1

1.37

1.36

u/field

0.01

373

(3015736) pH of Urine

2974

28598

1.06

1.90

4.1

3.7

6.23

0.03

1633

15639

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

1117

0.75

1.90

1.2

1.34

1.47

g/l

4.27

1117

(3024980) IgG subclass 4 [Mass/volume] in Serum

129

1020

1.27

1.88

1.6

1.7

0.81

0.94

g/l

0.39

804

(37208534) Antinuclear antibody arbitrary concentration in serum

158

1.71

1.88

1.0

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

152

1.71

1.82

1.3

1.6

10.19

9.76

ug/l

0.16

152

(3017704) Immunofixation for Urine

502

1.38

1.81

1.2

1.5

—

(3012441) Differential panel - Pleural fluid

147

1187

1.24

1.81

1.5

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

101

1.88

1.80

1.0

1.1

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

394

1.42

1.78

1.7

1.9

3.86

2.46

u/field

0.56

272

(3028026) IgM [Mass/volume] in Serum or Plasma

442

3928

1.13

1.77

1.5

1.9

1.22

1.35

g/l

0.81

410

3536

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

299

3444

0.86

1.75

1.2

1.3

26.95

59.64

au/ml

2.43

238

(3020876) Protein [Mass/time] in 24 hour Urine

142

1149

1.24

1.73

2.4

1.31

1.28

g/24h

0.05

672

(3000475) Leukocytes [#/volume] in Synovial fluid

231

1963

1.18

1.71

1.6

1.5

13501.88

16541.03

e6/l

0.52

162

1369

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.88

1.70

1.1

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

203

1707

1.19

1.69

1.8

11.82

12.84

mg/l

0.79

187

1588

(3017461) Flecainide [Moles/volume] in Serum or Plasma

0.00

1.69

0.0

1.4

—

0.84

—

(4024509) Urine culture

284

3273

0.86

1.68

1.9

2.0

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

4422

45314

0.95

1.67

4.1

3.9

15.09

15.05

pmol/l

0.48

4026

40627

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

172

1.63

1.66

1.0

1.1

103.14

93.83

0.85

134

(3035320) C reactive protein [Mass/volume] in Body fluid

511

1.35

1.65

3.5

2.8

35.82

33.72

mg/l

0.13

394

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

525

0.67

1.64

1.2

1.4

159.31

177.63

pmol/l

0.30

525

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

376

1.41

1.64

1.1

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

393

1.40

1.63

1.1

1.2

—

(40762887) Creatinine [Moles/volume] in Blood

2.25

1.63

1.1

1.7

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

205

1.56

1.61

1.5

1.4

26.50

25.88

g/l

0.09

155

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

386

1.40

1.60

1.1

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

386

1.40

1.60

1.1

1.2

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

135

1099

1.23

1.58

1.4

1.3

439.86

390.29

u/l

0.16

125

1037

(3012565) Volume of 24 hour Urine

337

1.43

1.58

2.5

2.4

1559.39

1933.13

1.58

277

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

3.00

1.58

1.0

1.3

1.33

0.92

u/field

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

109

1360

0.80

1.56

1.3

1.4

1812.78

961.69

e6/l

0.37

1078

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

355

1.41

1.55

1.2

1.4

14.04

5.98

u/l

1.23

305

(3048929) Epstein Barr virus Ab [Presence] in Serum

160

1329

1.21

1.55

1.4

1.2

—

(3023199) Leukocytes [#/volume] in Pleural fluid

165

1377

1.20

1.52

1.5

1082.22

2803.67

e6/l

1.73

110

973

(3001893) Eosinophils/Leukocytes in Pleural fluid

332

1.42

1.51

1.6

1.4

2.09

2.46

0.12

278

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

408

1.37

1.51

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

239

2062

1.16

1.50

1.5

1.6

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

383

1.39

1.50

1.1

96.76

93.54

u/l

0.11

335

(3019150) Specific gravity of Urine by Refractometry

1663

15820

1.06

1.49

4.7

4.5

1.02

1.11

kg/l

0.51

1157

10803

(4268621) Lupus anticoagulant assay

547

1.32

1.49

2.2

2.3

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

275

1.46

1.48

1.2

1.4

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

276

1.45

1.46

2.2

1.9

24863.00

13710.16

e6/l

0.32

155

(3000093) Morphology [Interpretation] in Blood Narrative

106

850

1.25

1.45

1.1

1.2

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

3.13

1.44

1.0

—

(3011325) HIV 1+2 Ab [Presence] in Serum

3.13

1.44

1.0

0.08

—

(3011985) Renin [Units/volume] in Plasma

115

932

1.24

1.43

1.3

1.4

85.54

73.75

mu/l

0.20

102

829

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2979

30749

0.95

1.42

2.5

2.4

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

337

3785

0.89

1.41

2.3

2.5

23.98

20.87

au/ml

0.21

290

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

4702

47993

0.95

1.41

4.9

4.5

15.87

14.03

mm/h

9.97

4400

44352

(3006922) Hepatitis E virus Ab [Presence] in Serum

448

1.34

1.41

1.1

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

149

1244

1.20

1.40

1.3

1.4

7.86

14.19

u/ml

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

380

1.37

1.39

1.1

24.48

30.77

u/l

0.54

330

(3035880) pH of Pleural fluid

597

1.29

1.39

1.4

1.3

7.41

0.04

411

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

142

1.62

1.38

1.0

1.3

87.00

93.48

0.39

130

(4034850) Laboratory test

236

2051

1.15

1.37

14.9

12.5

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

5895

59815

0.95

1.37

6.6

5.7

6.47

6.15

mmol/l

43.74

5422

53891

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

2.20

1.36

2.2

2.0

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

110

1344

0.82

1.34

1.2

1.3

31.31

27.10

e6/l

0.09

993

(3015171) Extractable nuclear Ab [Units/volume] in Serum

229

1992

1.15

1.33

1.3

1.2

1.61

0.70

u/ml

0.36

163

(3024263) Appearance of Synovial fluid

401

1.35

1.33

1.4

1.6

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

146

1224

1.20

1.32

1.4

1.5

141517.43

56888.17

e6/l

0.70

707

(46234826) Other cells/Leukocytes in Peritoneal fluid by Manual count

1.97

1.32

1.3

2.0

23.00

16.63

—

(40757494) Bilirubin.total [Moles/volume] in Blood

419

1.34

1.31

2.4

2.1

30.83

38.13

umol/l

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

122

1471

0.83

1.30

2.6

1.7

4.88

5.55

mg/l

0.25

108

1109

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

176

1503

1.17

1.30

1.3

1.2

105.00

268.06

titre

2.12

108

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

250

1.44

1.30

1.2

1.10

1.08

ratio

0.27

204

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

137

1.61

1.29

1.1

1.2

80.60

82.31

0.09

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

5753

56659

1.05

1.29

5.8

4.6

1.37

1.30

mmol/l

9.30

5364

50975

(3002179) Metamyelocytes/Leukocytes in Blood

682

6320

1.09

1.28

4.0

4.1

0.66

0.72

0.24

231

2130

(3044927) Protein electrophoresis panel - Urine

111

910

1.22

1.28

1.2

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

107

874

1.23

1.27

1.1

1.67

1.55

g/l

2.08

794

(3023487) Leukocytes [#/volume] in Peritoneal fluid

320

1.38

1.24

2.1

13465.75

3543.31

e6/l

0.34

223

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

176

1510

1.17

1.24

1.3

1.2

130.00

226.43

titre

—

(3021440) Promyelocytes/Leukocytes in Blood

684

6352

1.08

1.23

4.1

4.3

0.05

0.12

3.32

209

1948

(3017181) Myelocytes/Leukocytes in Blood

716

6662

1.08

1.23

4.2

0.86

0.96

0.56

242

2242

(3002619) Bacteria identified in Specimen by Culture

179

1.51

1.23

1.6

1.2

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

139

1.58

1.22

1.1

1.4

75.60

80.19

0.21

(40768793) Breast Pathology biopsy report

810

0.78

1.22

1.3

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

549

0.73

1.22

1.3

2.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

135

1135

1.19

1.21

1.2

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

490

0.71

1.20

1.3

1.2

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

151

1284

1.18

1.20

1.7

1.8

3.98

8.72

iu/l

0.45

454

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

461

1.30

1.20

2.6

2.0

151.26

118.46

ng/l

1.14

461

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

171

1472

1.16

1.17

1.3

1.2

4.13

5.94

u/ml

0.29

140

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

171

0.53

1.17

1.3

1.1

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.00

1.16

1.3

1.4

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

819

8723

0.93

1.15

11.2

8.4

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

392

0.69

1.15

2.1

1.8

600.73

341.21

mu/l

0.37

295

(3020911) Cortisol [Moles/time] in 24 hour Urine

166

1.51

1.14

1.2

1.4

77.42

468.24

nmol/24h

1.40

166

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

152

1772

0.86

1.14

2.7

3.5

970.44

901.26

u/ml

0.04

136

1630

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

171

1477

1.16

1.13

1.3

1.2

5.80

5.51

u/ml

0.05

215

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

178

1543

1.16

1.12

1.3

1.2

39.26

36.25

u/ml

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

250

1.40

1.12

1.3

1.5

15.60

13.13

g/l

0.86

188

(3016650) Hepatitis A virus Ab [Presence] in Serum

115

962

1.20

1.11

1.1

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

423

1.30

1.11

1.7

1.3

1.28

1.13

nmol/l

0.31

305

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

781

1.22

1.10

1.4

1.7

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

305

2744

1.12

1.10

1.8

1.7

37.12

38.34

u/l

0.43

249

2351

(3028707) Methadone [Presence] in Urine by Screen method

354

1.33

1.09

1.4

2.1

—

(37021550) Renin [Units/volume] in Plasma --upright

137

0.51

1.09

1.3

86.00

65.62

mu/l

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

201

1.44

1.09

1.3

1.1

2.00

8.72

u/ml

—

(3013466) aPTT in Blood by Coagulation assay

2.38

1.09

1.0

1.1

49.00

38.49

—

(3052912) Proteinase 3 IgG Ab [Units/volume] in Serum

160

1.50

1.09

1.0

1.1

—

21.27

—

(3000494) Fungus identified in Specimen by Culture

764

8136

0.93

1.08

1.5

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

2.19

1.08

1.1

1.2

231.63

262.26

nmol/l

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

581

0.76

1.07

1.6

1.5

151.60

276.03

pmol/l

1.69

563

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1109

11664

0.94

1.07

1.3

2.07

1.94

u/ml

0.13

255

2950

(3025549) Creatine [Moles/time] in 24 hour Urine

1.92

1.06

1.8

1.5

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

343

3113

1.11

1.06

5.1

4.0

24.31

24.78

mmol/l

2.11

315

2796

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

348

1.32

1.05

2.0

2.48

1066.82

u/l

0.66

105

(3016038) Potassium [Moles/volume] in Urine

534

1.26

1.04

1.1

36.74

35.91

mmol/l

0.10

459

(3009871) Measles virus Ab [Titer] in Serum

171

1.46

1.02

1.5

4053.33

3512.50

titre

—

(3037756) Immunofixation for Serum or Plasma

228

2028

1.13

1.01

1.4

1.5

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

626

1.23

1.01

1.2

1.4

0.40

0.45

g/l

0.82

455

(3027135) IgG subclass 1 [Mass/volume] in Serum

626

1.23

1.01

1.2

1.4

6.67

7.06

g/l

0.42

455

(3028192) IgG subclass 2 [Mass/volume] in Serum

626

1.23

1.01

1.2

1.4

2.63

3.06

g/l

2.05

459

(3017732) Neutrophils [#/volume] in Blood

776

8235

0.94

1.00

3.8

3.3

5.44

4.85

e9/l

0.94

653

6886

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

457

1.27

1.00

1.1

1.2

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

147

1272

1.16

0.98

1.3

1.2

3.44

4.57

u/ml

0.20

(3015377) Calcium [Moles/volume] in Serum or Plasma

2388

24590

0.96

0.98

3.6

2.34

mmol/l

1.11

2162

22123

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

156

1.48

0.98

1.2

1.0

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.67

0.97

1.6

2.0

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

0.97

0.0

1.4

—

30.55

—

(4062490) Immunoglobulin typing, IgG

621

1.23

0.96

1.2

1.4

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

668

6268

1.07

0.96

1.8

1.69

1.59

1.55

551

5261

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

273

2464

1.11

0.96

1.9

1.7

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

210

0.62

0.94

1.0

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

549

5122

1.08

0.93

1.5

1.4

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.73

0.92

1.2

1.3

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

102

864

1.18

0.91

1.3

11.21

13.92

u/l

1.02

789

(3047007) Chlamydophila sp Ab [Presence] in Serum

590

1.22

0.90

1.2

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

393

1.27

0.90

1.2

1.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

746

1.20

0.89

1.5

1.8

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

156

0.58

0.87

1.3

1.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

1.61

0.87

1.4

1.3

—

(3016018) Differential panel - Cerebral spinal fluid

661

0.80

0.87

1.2

1.3

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

307

1.30

0.86

2.8

2.2

781.05

1271.81

u/ml

1.92

301

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

168

0.59

0.86

2.2

2.1

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

102

870

1.17

0.85

1.2

1.3

192.60

282.96

pmol/l

4.83

714

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

778

1.18

0.85

1.1

—

(1761868) Lipid panel - Serum or Plasma

1908

19676

0.96

0.84

4.5

3.6

—

(40762365) Oxygen content in Arterial blood by calculation

162

1.42

0.84

3.5

2.8

15.48

14.74

ml/dl

0.68

150

(3010144) Erythrocytes [#/volume] in Synovial fluid

752

1.19

0.83

1.3

51997.04

168947.21

e6/l

3.08

500

(3025159) Blasts/Leukocytes in Blood

671

6338

1.06

0.82

4.3

4.4

0.07

0.25

1.73

193

1839

(3005719) IgG [Mass/volume] in Serum or Plasma

530

4969

1.07

0.82

2.4

2.8

10.53

10.82

g/l

0.68

496

4541

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

275

1.31

0.81

1.2

2.0

3460.14

52502.98

u/ml

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

209

1881

1.11

0.81

1.5

4.53

12.25

iu/ml

0.71

417

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

236

0.68

0.80

13.9

20.0

1429.13

1371.74

nmol/l

0.12

228

(3005322) IgE [Units/volume] in Serum or Plasma

297

3234

0.92

0.80

1.3

221.70

301.99

u/ml

1.18

272

2985

(4211845) Urine protein measurement

338

1.27

0.79

2.6

3.7

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

793

1.17

0.79

1.2

1.3

1.46

1.47

nmol/l

0.02

712

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

0.00

0.79

0.0

1.0

—

(3022475) Manganese [Moles/volume] in Blood

0.00

0.79

0.0

1.5

—

0.18

—

(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid

0.00

0.79

0.0

1.0

—

10857.25

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

567

6019

0.94

0.79

1.3

—

(3045414) Leukocytes [Presence] in Urine

652

6886

0.94

0.77

2.3

2.1

0.04

0.01

estimate

0.44

111

1303

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

222

0.68

0.77

10.4

15.5

956.67

814.98

nmol/l

0.52

211

(3000012) Reticulocyte production index

169

1509

1.12

0.76

2.0

2.1

0.95

0.89

0.84

127

1076

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

1.70

0.75

1.5

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

1.52

0.75

1.1

1.3

85.20

76.30

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

2.08

0.74

1.0

0.13

0.01

u/ml

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

184

1.36

0.73

1.2

1.3

—

(3046861) Legionella sp Ag [Presence] in Urine

1.64

0.73

1.3

1.0

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

133

1.43

0.73

1.4

1.5

—

(3008295) Osmolality of Serum or Plasma

841

0.84

0.73

1.2

1.3

280.88

277.86

mosm/kgh2o

0.50

621

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

656

0.82

0.73

1.3

2.0

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

100

1.50

0.72

1.1

1.4

95.00

76.69

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.61

0.72

1.0

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

6027

60820

0.97

0.72

7.9

6.3

1.98

2.50

mmol/l

307.65

5680

55582

(3002079) Sodium [Moles/time] in 24 hour Urine

264

1.29

0.71

1.2

1.3

179.65

182.27

mmol/24h

0.05

264

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

220

2004

1.10

0.71

1.6

37.31

26.28

u/ml

0.51

370

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.58

0.71

1.7

1.6

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

170

0.65

0.70

2.1

2.0

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

356

3314

1.08

0.70

2.4

2.7

—

(3021601) Nitrite [Presence] in Urine by Test strip

3600

35389

1.03

0.70

4.6

4.1

0.00

estimate

1.08

790

7725

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

181

0.66

0.69

1.2

1.1

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

248

1.29

0.68

1.1

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

1.67

0.68

1.0

1.1

—

2.67

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

593

1.18

0.68

1.1

4.88

3.24

—

(3014271) Vancomycin [Susceptibility]

520

1.19

0.67

3.2

3.0

—

(3034426) Prothrombin time (PT)

170

1.35

0.67

1.2

1.3

29.00

28.51

0.09

170

(3003327) Ova and parasites identified in Stool by Light microscopy

184

1668

1.11

0.66

1.6

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

179

1.34

0.66

1.5

2.4

217.21

209.79

0.11

169

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.79

0.66

1.6

2.3

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

167

0.66

0.65

1.8

2.4

1.19

0.99

ug/l

0.10

155

(21494434) Karyotype in Bone marrow

753

1.16

0.65

1.1

1.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

403

1.22

0.65

2.1

2.0

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

190

0.68

0.65

1.4

1.1

—

(3009261) Glucose [Presence] in Urine by Test strip

3660

36019

1.03

0.65

4.7

4.2

1.43

0.24

estimate

0.40

715

7352

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

180

1.33

0.64

1.1

1.2

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

233

1.29

0.64

1.1

1694.46

1537.43

miu/ml

0.34

233

(3014765) Yersinia sp identified in Stool by Organism specific culture

181

1644

1.10

0.64

1.2

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

578

0.83

0.62

1.4

1.3

322.00

74.78

titre

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

228

2098

1.09

0.62

1.2

1.3

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

501

0.82

0.61

1.1

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.67

0.61

1.0

1.2

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

164

0.67

0.61

1.2

1.1

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.60

0.61

2.9

5.5

—

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

1.60

0.61

1.4

1.5

17.41

19.86

pmol/l

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.60

0.61

1.0

1.1

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

425

4007

1.06

0.61

2.6

2.5

—

(3021960) Folate [Moles/volume] in Serum or Plasma

2324

22742

1.03

0.60

1.9

1.8

17.69

19.58

nmol/l

9.65

2025

19298

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

412

0.80

0.60

2.4

2.6

33.70

36.37

0.38

224

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.59

0.0

1.0

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.59

0.0

1.1

—

3.18

—

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

183

1.31

0.59

1.1

1.2

28.22

34.46

0.43

116

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

377

0.79

0.58

1.4

1.3

0.24

2.16

u/ml

3.11

222

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

179

1635

1.10

0.58

1.2

—

(3031040) Bacteria [#/volume] in Urine by Automated count

4579

45249

1.03

0.58

5.6

5.2

762.79

1786.63

e6/l

1.90

111

782

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

219

2020

1.09

0.57

1.3

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

409

0.81

0.57

1.1

6.63

8.58

nmol/l

0.22

(3009466) Valproate [Moles/volume] in Serum or Plasma

979

0.88

0.57

3.3

4.6

325.23

338.30

umol/l

0.38

829

(3020650) Glucose [Presence] in Urine

207

0.72

0.56

1.4

1.7

0.00

0.04

estimate

1.08

207

(3000764) Benzodiazepines [Presence] in Urine

755

1.14

0.56

1.4

1.8

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

172

0.70

0.56

1.2

1.1

—

(3019174) dRVVT (LA screen)

1.62

0.55

1.3

1.2

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

430

1.19

0.55

1.3

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

430

1.19

0.55

1.3

1.4

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

625

1.15

0.55

1.2

7.91

7.85

mmol/l

0.05

524

(3026389) Candida sp identified in Specimen by Organism specific culture

775

1.14

0.55

1.3

1.4

—

(3027944) Amphetamines [Presence] in Urine

747

1.14

0.55

1.4

1.8

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

461

0.82

0.55

1.1

0.25

0.98

u/ml

2.45

236

(42529406) Shigella sp [Presence] in Stool by Culture

180

1651

1.09

0.55

1.2

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

171

0.70

0.54

1.2

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

160

1.31

0.53

1.2

1.6

—

(3035350) Ketones [Presence] in Urine by Test strip

3634

35838

1.02

0.53

4.6

4.2

5.19

4.27

estimate

0.11

810

7937

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

665

1.14

0.53

1.4

1.6

—

(3011544) Albumin [Mass/volume] in Pleural fluid

108

1.39

0.53

1.3

1.1

14.87

16.88

g/l

0.57

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

599

0.85

0.53

1.4

1.3

53.33

263.65

titre

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1865

18233

1.03

0.52

4.4

3.7

0.08

0.27

estimate

1.14

615

5940

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

675

1.14

0.52

1.1

8.33

19.40

au/ml

—

116

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.45

0.51

2.3

1.6

63.17

44.88

umol/l

0.55

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

144

1578

0.91

0.51

3.9

3.6

40.26

94.59

u/ml

4.10

135

1515

(3006462) Nitrate [Presence] in Urine

305

1.21

0.51

2.9

3.9

—

(3007164) IgA [Mass/volume] in Serum or Plasma

1025

10577

0.96

0.51

1.5

2.85

2.77

g/l

0.44

618

6264

(3004616) Nuclear Ab [Presence] in Serum

767

0.87

0.50

1.3

1.2

—

(3037121) Protein [Mass/volume] in Urine

288

2703

1.07

0.50

2.8

3.2

415.25

532.92

mg/l

0.58

160

1265

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

454

1.17

0.49

1.6

1.9

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

346

0.81

0.49

1.1

1.0

1.25

0.29

u/ml

0.60

132

(3042010) Triglyceride [Moles/volume] in Pleural fluid

171

1.29

0.49

1.3

0.36

1.62

mmol/l

1.66

115

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

551

0.85

0.49

1.1

—

41.26

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

1039

0.89

0.49

1.3

1.8

252.64

282.32

mu/l

0.74

969

(3028433) Virus identified in Specimen by Culture

235

1.23

0.48

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

235

1.23

0.48

1.6

1.8

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

208

1.25

0.47

1.3

1.2

12.59

14.68

pmol/l

0.24

(3016879) Cocaine [Presence] in Urine

710

1.13

0.47

1.4

1.9

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

591

0.86

0.46

1.1

—

9.60

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

182

1.26

0.46

3.1

2.4

306.13

218.50

ug/l

0.13

182

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2540

24982

1.02

0.46

2.2

2.0

1.36

1.33

mmol/l

0.87

2161

20565

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

483

0.85

0.46

1.4

1.5

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

119

1306

0.91

0.46

1.3

1.4

10.42

8.25

u/l

1.00

1042

(3032773) Endomysium IgG Ab [Titer] in Serum

477

1.15

0.45

1.1

—

(4212803) Bone marrow aspirate examination

0.59

0.45

1.0

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

0.59

0.45

1.0

1.1

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

385

0.83

0.45

1.3

1.5

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

385

0.83

0.45

1.3

1.5

—

(3023410) Appearance of Cerebral spinal fluid

557

0.86

0.45

1.4

—

(3021788) Differential panel - Synovial fluid

158

1459

1.08

0.44

1.6

1.5

—

1.00

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

329

0.82

0.43

1.2

1.5

0.18

0.17

nmol/l

0.07

239

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

157

1.27

0.43

1.5

1.2

0.32

0.31

g/l

0.50

120

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

489

1.15

0.43

3.6

3.8

—

(3028300) Cannabinoids [Presence] in Urine

763

1.12

0.43

1.4

1.8

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

830

1.11

0.42

3.4

3.0

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1.38

0.42

1.6

—

(3003694) ABO and Rh group [Type] in Blood

1762

17276

1.03

0.41

1.3

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

3923

39646

0.98

0.41

3.9

3.4

64.79

58.39

u/l

2.77

3657

36547

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.43

0.41

1.1

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

1.52

0.41

1.4

1.7

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

942

0.90

0.41

1.4

1.5

66.54

63.35

0.32

605

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1481

15128

0.97

0.40

3.3

3.2

2.47

2.46

mmol/l

1.75

1288

13473

(1002224) Polysomnography panel

198

2113

0.94

0.40

1.1

—

(3047189) Immunofixation for 24 hour Urine

445

1.15

0.40

1.3

1.6

—

(3014339) Estrone (E1) [Moles/volume] in Serum or Plasma

0.00

0.40

0.0

1.0

—

226.54

—

(3036071) Salmonella sp Ab [Titer] in Serum

150

1.27

0.40

1.1

—

(3014891) Appearance of Pleural fluid

159

1.26

0.40

1.9

1.5

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

3396

33563

1.02

0.39

2.4

2.3

91.27

92.75

pmol/l

1.15

1928

18740

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1.43

0.39

1.4

1.5

60.16

54.70

ug/l

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

0.39

0.0

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

325

1.17

0.39

1.3

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

251

1.20

0.39

1.0

1.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

749

0.89

0.38

1.4

28.47

26.00

iu/l

0.22

611

(3020393) Adenovirus Ag [Presence] in Stool

1.36

0.38

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

1.39

0.38

1.4

1.2

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

136

1260

1.08

0.38

1.3

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.32

0.37

1.6

1.4

—

(3027008) Opiates [Presence] in Urine

762

1.10

0.37

1.4

1.8

—

(3051101) Glucose [Moles/volume] in Cord blood

161

1.24

0.37

5.2

6.5

8.92

8.66

mmol/l

0.24

161

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

169

0.77

0.36

1.1

1.2

15.08

11.30

mm/h

0.33

169

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.39

0.36

1.0

1.1

—

(40762814) Titanium [Mass/volume] in Blood

143

1.26

0.36

2.2

2.4

3.40

3.57

ug/l

—

(36660697) Celiac disease serology panel - Serum

391

4076

0.96

0.36

1.2

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

1.27

0.36

1.1

1.3

—

(3026726) Creatinine [Moles/volume] in Specimen

0.62

0.35

3.2

2.3

339.20

494.25

umol/l

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.36

0.34

1.0

1.3

—

(3010838) Calcium [Moles/time] in 24 hour Urine

108

997

1.08

0.34

1.6

1.8

3.89

4.61

mmol/24h

1.56

852

(3003888) Timothy IgE Ab [Units/volume] in Serum

521

0.88

0.34

1.0

1.1

1.71

3.64

u/ml

1.44

249

(3008401) Mugwort IgE Ab [Units/volume] in Serum

510

0.88

0.33

1.0

1.1

0.51

1.05

u/ml

0.60

218

(3025130) Human papilloma virus identified in Specimen

228

1.18

0.33

2.1

1.9

—

(3003181) Sodium [Moles/volume] in Urine

148

1579

0.94

0.33

1.4

1.3

64.78

60.78

mmol/l

0.70

115

1269

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

146

1.23

0.32

1.1

1.2

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

5933

59021

1.02

0.31

9.3

7.3

43.32

40.61

mmol/mol

70.46

5597

54326

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

380

1.13

0.31

1.5

2.3

382.16

518.50

e6/l

0.97

312

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.32

0.30

1.0

1.2

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

109

1014

1.08

0.30

1.0

1.1

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

103

1.26

0.28

1.3

1.2

7.25

8.37

mg/l

0.29

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

1.28

0.28

2.7

2.8

99.33

55.66

mg/l

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

407

0.88

0.27

1.1

0.71

1.84

u/ml

1.72

210

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

824

0.92

0.27

1.2

102.29

190.79

miu/ml

—

248

(40758292) HTLV I+II Ab panel - Serum

119

0.76

0.27

1.1

1.3

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

185

1944

0.95

0.27

1.4

1.6

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

6176

62014

0.98

0.27

27.8

20.2

29.58

29.07

mg/l

0.57

5641

53158

(3008757) Leukocyte morphology finding [Identifier] in Blood

855

1.08

0.27

3.2

4.2

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

131

1.22

0.27

2.2

5.0

42.75

64.61

u/l

0.72

126

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

139

0.79

0.26

1.3

1.2

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

374

0.88

0.26

4.7

4.1

126.46

53.23

u/ml

0.33

368

(40765096) Chromosome analysis panel by Banding

268

0.86

0.26

1.2

1.1

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

5918

59437

0.98

0.26

6.8

5.4

3.71

4.34

mmol/l

307.65

5601

54514

(3050794) Legionella sp Ab [Presence] in Serum

1.19

0.26

1.0

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

635

0.91

0.26

1.1

1.14

1.61

u/ml

0.35

353

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

256

0.86

0.25

1.0

1.1

1.48

1.14

u/l

—

119

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

188

1.17

0.25

1.1

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

245

1.14

0.24

1.6

1.4

1820656.00

1007177.67

iu/ml

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

4916

48886

1.01

0.24

35.6

26.1

330.82

332.10

g/l

18.41

4871

48496

(3032057) Clostridioides difficile [Presence] in Stool

189

1.16

0.24

2.5

1.9

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

398

1.11

0.23

1.3

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

398

1.11

0.23

1.3

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

398

1.11

0.23

1.3

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

398

1.11

0.23

1.3

1.9

—

(4146454) Self-monitoring of blood glucose

920

0.93

0.23

2.8

2.7

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

558

0.91

0.23

1.2

1.4

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.28

0.23

13.4

9.2

—

(40768441) Liver Pathology biopsy report

476

1.09

0.23

1.4

1.3

—

(40768797) Stomach Pathology biopsy report

915

9311

0.98

0.22

1.3

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

472

0.91

0.21

2.3

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.21

0.0

1.0

—

(3021367) Citalopram [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.3

—

147.80

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.21

0.0

1.0

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.1

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.21

0.0

2.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.21

0.0

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(3041806) Other cells [#/volume] in Blood by Manual count

0.00

0.21

0.0

1.4

—

0.60

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.21

0.0

2.0

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

0.21

0.0

1.5

—

342.09

—

(36660577) Edoxaban [Mass/volume] in Platelet poor plasma by Chromogenic method

0.00

0.21

0.0

1.6

—

100.29

—

(3001556) Androgen free Index in Serum or Plasma

0.00

0.21

0.0

1.2

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.21

0.0

1.2

—

1829.23

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.3

—

30.69

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.21

0.0

1.8

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

173

1.16

0.20

1.8

2.4

7.42

8.09

mmol/l

0.46

110

(3008898) HLA-B27 [Presence]

118

1242

0.95

0.20

1.0

1.1

—

(3011412) CD3 cells [#/volume] in Blood

595

1.08

0.20

1.5

2.2

902.09

1078.46

e6/l

1.09

538

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

211

1.14

0.20

1.0

—

(3013637) Mi-2 Ab [Presence] in Serum

211

1.14

0.20

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

211

1.14

0.20

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

211

1.14

0.20

1.0

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

249

1.12

0.20

1.1

1.0

10.09

11.90

iu/ml

—

(3034459) Mononuclear cells/Leukocytes in Pleural fluid

117

1.20

0.20

1.6

1.4

68.12

74.16

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

780

1.06

0.20

1.4

13.65

13.30

u/l

0.26

748

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

1.25

0.20

1.0

1.2

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

674

1.07

0.20

1.4

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

674

1.07

0.20

1.4

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

674

1.07

0.20

1.4

1.7

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.21

0.19

1.2

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

375

0.91

0.19

1.1

0.42

2.50

u/ml

2.71

166

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

133

0.83

0.19

1.5

1.4

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

578

1.07

0.19

1.4

1.8

—

(4133840) Spirometry

154

0.84

0.19

1.2

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.13

0.18

1.2

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

332

0.90

0.18

1.1

—

(3034092) Cytoplasmic Ig cells/cells in Blood

1.21

0.18

28.1

11.1

0.21

0.23

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

886

8994

0.98

0.18

1.3

17.21

13.62

u/ml

0.57

334

3152

(3042631) Mycobacterium sp identified in Specimen

134

1283

1.05

0.18

2.7

—

(3004809) Band form neutrophils/Leukocytes in Blood

152

1460

1.04

0.18

3.3

3.8

1.63

1.54

0.12

139

1277

(44806420) Estimation of glomerular filtration rate

522

1.07

0.17

2.5

2.6

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.17

0.17

1.0

1.5

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

4936

49152

1.01

0.17

34.1

24.8

14.21

13.92

33.00

4870

48437

(3048689) Calprotectin [Mass/mass] in Stool

633

6443

0.98

0.17

2.6

2.3

197.96

164.91

ug/g

0.85

524

5136

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

142

0.84

0.17

1.3

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

368

1.09

0.17

1.2

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

568

0.93

0.17

1.2

1.4

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1629

16131

1.01

0.16

1.8

18608477.54

26103642.24

pmol/l

0.32

1365

13098

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.14

0.16

6.6

3.9

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2670

26516

1.01

0.16

4.8

4.3

0.33

0.28

estimate

0.08

664

6363

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

292

1.10

0.16

1.4

2.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

292

1.10

0.16

1.4

2.2

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.78

0.15

1.3

1.1

—

(44786800) Granulocytes/Leukocytes in Body fluid

130

1.15

0.15

1.4

1.3

16.09

23.92

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.77

0.15

1.0

—

(4281824) Cell count and differential, peritoneal fluid

507

1.07

0.15

1.2

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

881

0.95

0.15

1.3

1.4

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

381

1.08

0.14

1.5

2.4

225.78

230.62

e6/l

0.05

337

(40757373) Influenza virus identified in Isolate

169

1.12

0.14

1.3

1.6

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

285

0.91

0.14

1.1

643.99

572.68

ng/l

—

(3029937) Albumin [Presence] in Urine by Test strip

2042

20567

0.99

0.14

4.7

4.3

0.00

estimate

0.28

666

6749

(4027681) Cerebrospinal fluid IgG ratio and IgG index

264

0.91

0.14

1.3

1.2

0.50

0.54

ratio

0.42

157

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

879

0.96

0.14

1.3

1.4

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

295

1.08

0.13

1.4

2.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

744

1.05

0.13

1.3

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

222

0.90

0.13

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

128

0.86

0.13

1.1

—

(3000060) B lymphocytes [#/volume] in Blood

117

0.85

0.13

1.7

1.9

2.29

1.26

e9/l

—

(3008536) Aspergillus sp Ab [Presence] in Serum

161

1.12

0.13

1.3

1.9

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

917

0.96

0.12

1.9

1.5

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

334

0.93

0.12

1.0

1.2

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

297

1.08

0.12

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

688

1.05

0.12

1.3

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

282

0.92

0.12

2.3

51.52

54.66

umol/l

0.15

236

(3017354) Segmented neutrophils/Leukocytes in Blood

945

0.96

0.11

2.6

3.7

59.80

58.51

0.24

793

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

199

0.90

0.11

1.1

1.2

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

964

9733

0.99

0.11

1.3

51.69

38.51

iu/ml

1.09

293

2882

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

343

0.93

0.11

1.1

—

(3045142) Bone marrow Pathology biopsy report

954

0.96

0.11

1.3

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.16

0.11

1.9

1.6

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

146

0.89

0.10

1.1

1.3

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

5882

58934

0.99

0.10

6.7

5.3

1.22

1.38

mmol/l

215.68

5535

53649

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

931

0.97

0.10

1.3

1.4

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.11

0.09

1.2

1.4

214.00

334.00

umol/24h

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

232

1.08

0.09

1.1

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.09

0.09

1.0

1.1

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

713

1.04

0.09

1.5

27.20

25.50

0.14

457

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.04

0.09

1.0

1.1

179.20

113.33

titre

—

(3025577) Chromium [Mass/volume] in Blood

513

0.95

0.09

2.2

2.1

2.35

2.03

ug/l

0.51

414

(3000034) Microalbumin [Mass/volume] in Urine

675

0.96

0.09

3.1

177.61

58.44

mg/l

0.71

512

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

675

1.04

0.09

1.6

18.20

29.68

u/ml

—

137

(3025468) Yersinia sp identified in Specimen by Organism specific culture

877

0.97

0.08

1.3

1.4

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.05

0.08

1.2

1.0

20.52

48.70

iu/ml

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

917

0.97

0.08

1.3

1.4

—

(40761536) Microorganisms panel - Urine sediment

548

5423

1.01

0.08

4.7

4.4

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1.03

0.08

1.0

1.6

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

224

1.07

0.08

1.0

1.1

17.44

22.83

u/ml

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

328

0.94

0.08

1.0

1.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

598

1.04

0.08

1.1

—

(3036603) Volume of Urine

529

1.04

0.08

1.2

1.7

1824.71

1883.99

0.23

515

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

113

1158

0.98

0.08

1.2

1.1

7.34

10.04

eliau/ml

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

254

1.06

0.07

2.9

25.50

28.68

umol/l

0.82

186

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.84

0.07

1.0

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

0.80

0.07

8.7

9.6

0.38

0.32

umol/l

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

104

1014

1.03

0.07

2.0

2.1

17.21

25.92

mg/l

1.90

358

(3026051) Granulocytes/Leukocytes in Pleural fluid

264

1.06

0.07

1.5

1.4

25.05

23.19

0.10

214

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

143

0.91

0.07

1.1

1.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

259

2627

0.99

0.07

1.2

99.43

117.39

u/ml

0.22

859

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

914

0.97

0.07

1.3

1.4

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

661

0.97

0.07

1.3

1.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

154

1511

1.02

0.07

1.6

1.5

—

(3033099) Centromere Ab [Titer] in Serum

118

1.10

0.07

1.1

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

0.88

0.06

6.1

5.6

54.38

46.97

ug/min

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

216

1.06

0.06

1.4

1.2

1.27

1.47

mmol/l

0.38

136

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.85

0.06

1.3

1.1

—

(3025941) Bacteria identified in Stool by Culture

315

3113

1.01

0.06

1.3

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

207

2101

0.98

0.06

1.4

1.6

—

(3049717) Cytology report of Urine Cyto stain

400

4040

0.99

0.06

2.7

2.9

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

234

0.94

0.06

1.3

1.2

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.11

0.06

1.0

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

157

1543

1.02

0.06

1.3

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

305

0.95

0.06

1.4

1.3

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

121

0.91

0.06

1.0

1.1

—

(21494814) CD8 cells/Lymphocytes in Specimen

277

1.05

0.05

1.3

1.9

24.86

32.27

2.30

277

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

130

0.92

0.04

1.2

1.1

—

(3036670) Protein [Mass/volume] in Synovial fluid

272

0.96

0.04

1.0

1.2

42.53

40.30

g/l

0.46

136

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

524

0.97

0.04

1.1

5.01

2.74

eliau/ml

0.66

175

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

332

0.96

0.04

1.8

40.89

39.49

g/l

0.79

332

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

160

1.06

0.04

1.1

1.2

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

619

6221

0.99

0.04

5.4

4.1

1.21

1.22

mmol/l

2.14

554

5368

(40760892) CBC W Ordered Manual Differential panel - Blood

1363

13671

1.00

0.04

5.3

4.9

—

(3003740) Influenza virus B Ag [Presence] in Specimen

597

1.02

0.03

1.1

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

139

0.94

0.03

1.1

1.4

—

96.44

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

492

0.98

0.03

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

159

0.94

0.03

1.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

320

0.97

0.03

1.3

1.4

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

311

1.03

0.02

1.2

1.1

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

305

3034

1.01

0.02

3.2

3.5

785.58

2179.93

u/ml

0.76

260

2632

(3000570) Elastase.pancreatic [Mass/mass] in Stool

219

2204

0.99

0.02

1.4

1.5

260.41

254.20

ug/g

0.18

148

1369

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

227

0.97

0.01

1.7

1.9

49.90

54.33

ug/l

0.28

218

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

642

1.01

0.01

1.2

1.4

—

(44813793) Dust mix specific IgE antibody measurement

303

1.02

0.01

1.1

1.0

—

(3011288) Drugs identified in Urine by Screen method Nominal

497

0.99

0.01

5.2

2.4

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

473

1.01

0.01

1.4

1.2

83.62

102.17

pmol/l

2.50

473

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.06

0.01

1.9

2.5

0.62

0.67

ug/l

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

124

1.05

0.00

1.0

1.2

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

146

0.96

0.00

2.0

1.7

—

(4015189) Microbial culture of sputum

216

0.97

0.00

2.1

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

236

0.97

0.00

7.6

6.4

77.69

71.76

0.76

186

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

126

1.03

0.00

1.2

1.3

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

351

1.00

0.00

1.3

211.42

380.15

ug/l

0.46

185

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

416

1.01

0.00

1.8

2.2

0.47

0.59

e9/l

0.84

392

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

259

1.00

0.00

1.2

5.86

6.20

mmol/l

0.96

244

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

155

1.03

0.00

1.4

1.2

56.56

256.08

u/l

—

108

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

857

8566

1.00

0.00

3.5

4.3

13.80

26.11

ug/l

1.47

714

7216

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

120

1199

1.00

0.00

1.1

3.45

3.58

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

376

1.01

0.00

3.2

3.5

0.87

1.24

0.64

376

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

183

0.98

0.00

1.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.02

0.00

2.0

2.8

0.40

0.38

u/field

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

0.0

1.1

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.0

6.9

—

0.27

—

(3046594) Interleukin 8 [Mass/volume] in Serum or Plasma

0.00

0.0

1.5

—

35.85

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

0.00

0.0

1.0

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

0.00

-0.00

0.0

1.1

—

(44806071) Cardiolipin IgM antibody measurement

1.02

-0.00

1.2

1.1

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

2.2

—

2.49

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

0.99

-0.00

1.1

1.0

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

0.95

-0.00

1.3

1.2

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.97

-0.00

1.3

1.1

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

3.64

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.01

-0.00

1.0

1.3

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

3444.14

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

0.00

-0.00

0.0

1.0

—

(3028717) Thiamine [Mass/volume] in Blood

0.99

-0.00

1.0

1.2

64.78

64.48

ug/l

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.94

-0.00

1.4

1.1

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

0.93

-0.00

1.1

2.1

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

2.0

—

349.89

—

(3033463) Neutrophils [#/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.0

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

0.00

-0.00

0.0

1.1

—

(3043614) Bacteria identified in Aspirate by Culture

0.00

-0.00

0.0

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.02

-0.00

1.5

1.6

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.01

-0.00

1.0

1.3

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

-0.00

0.0

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.01

-0.00

1.0

1.3

—

(3003095) Rheumatoid factor [Units/volume] in Synovial fluid

0.00

-0.00

0.0

1.0

—

(3008896) Cortisol [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

88.60

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.1

—

1.57

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3021374) Sirolimus [Mass/volume] in Blood

0.00

-0.00

0.0

6.2

—

7.73

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: I9_STEMI – Myocardial infarction, with ST-elevation

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Myocardial infarction, with ST-elevation

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Myocardial infarction, with ST-elevation (I9_STEMI)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints